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CHAPTER 1: INTRODUCTION
Background and Significance
Mechanical interventions in wound healing and repair have been used since the
ancient Egyptians, who were the first documented cases of splinting broken or injured
limbs (Fess 2002). While medical practices have advanced significantly since then,
mechanical interventions have and will continue to be necessary for some injuries, at
least for the foreseeable future. With this in mind, this body of work sets to investigate
some of these mechanical interventions that are designed to promote wound healing,
repair, or even replace an injured tissue.
Traditionally, describing the effectiveness of mechanical interventions has been
simply a matter of whether or not mechanical integrity was restored to the damaged
tissue. For example, the success of the earliest splints was determined by observed
improvements in the healing of broken bones. However, mechanical interventions can
have physiological effects, both expected and unexpected, that can drastically affect other
aspects of the tissue’s performance. These physiological effects can range from providing
temporary support to damaged protein filaments, to directly affecting gene expression in
cells, to altering system-wide physiological responses to an injury. The purpose of this
work is to investigate a range of previously used mechanical interventions and determine
the physiological effects, both expected and unexpected.
Firstly, one of the most widely used and simple mechanical interventions is
investigated. The use of sutures to close wounds to promote faster healing is a practice
familiar to the general public. Human skin samples were sutured and loaded in tension in
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multiple orientations to determine how the injury and suture treatment change the tensile
mechanics of our most superficial organ. Next, the cellular component of tissue
engineering was addressed. Specifically, a unique biochemical and mechanical approach
was take to create a meniscus cell source from human adipose-derived stem cells.
Thirdly, the inflammatory (biochemical) effects of decellularized ECM in a wound healing
model were analyzed. A commercially available decellularized material, porcine small
intestine submucosa (SIS), was evaluated as a patch treatment in a rat myocardial
infarction model. While the mechanical benefits of an SIS patch treatment have been
established, it was previously unknown how this decellularized tissue would affect
inflammation, and therefore wound healing, of such a critical injury. While each of these
individual works focuses on a different tissue system, each tissue system presents with
specific injuries that can be aided by mechanical interventions. These tissue systems and
mechanical interventions are described, tested, and discussed in the following pages.
Skin Mechanics
The integument system, also known as skin, is a three-layered organ that covers
the entire body and serves as a physical barrier to protect the body from its surrounding
environment. To function properly, skin must be strong and durable but flexible enough
to allow movement. This is accomplished through an extracellular matrix (ECM),
comprised of vast networks of collagens and elastin fibers as well as a complex population
of glycosaminoglycans (GAGs) and proteoglycans (Corr 2011). While all components are
present in each of the three layers, it is the largest layer, the dermis, that bears the
greatest responsibility for the skin’s mechanical behavior. Several types of collagen are
present in the skin, although collagen I has the greatest direct contribution to tissue
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mechanics, and therefore will be the main focus of this analysis. Collagen I in its mature
form consists of globular collagen units covalently bonded into a right-hand triple helix
filament (Holzapfel et al. 2000). Collagen I is very strong and stiff when stretched along
its long axis, with an elastic modulus in the range of 5- 10 GPa (Wenger et al. 2007). By
dry weight, collagen I accounts for 60-80% of skin, and therefore is the dominating protein
in skin’s mechanical behavior (Holzapfel et al. 2000). Elastin is another fibrous ECM
protein and it accounts for 5-10% of skin by dry weight (Holzapfel et al. 2000). Elastin
differs from collagen I in that its fibril structure is seemingly more organized. This
organization is key to its mechanical behavior. Under tension, the fibrils display entropic
straightening, resulting in energy “absorption” in the filament (Holzapfel et al. 2000). The
elastin fibers have various dominating orientations depending on the location of the skin
on the body, yet is always aligned with the layers of the skin (Holzapfel et al. 2000). Also
present in the skin are proteoglycans, the most common of which is versican (Carrino et
al. 2011). Proteoglycans are heavily glycosylated proteins that act to retain water in the
tissue (Carrino et al. 2011, Holzapfel et al. 2000). In tensile skin mechanics,
proteoglycans act as lubricants easing movement of collagen filaments past each other
as tension is applied (Carrino et al. 2011, Holzapfel et al. 2000). This unique combination
of ECM proteins gives rise to viscoelastic mechanical behavior, in that the tissue behaves
in a time-dependent fashion when under load (Corr et al. 2011). Under non-loading
conditions, collagen I fibrils are crimped and disorganized among proteoglycans and
elastin fibrils (Holzapfel et al. 2011). The crimped, random organization of collagen can
be seen in Figure 1, along with the organization of elastin fibrils.
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When a load is applied in tension, the ECM proteins undergo three distinct phases.
The first phase involves primarily the uncoiling and straightening of elastin filaments. The
absorption of energy by elastin filaments results in minimal strain, or lengthening, of
collagen and of the tissue as a whole. Rather, the elastin filaments straighten and stretch,
preserving the overall integrity of the tissue (Holzapfel et al. 2000, Langdon et la. 2017).
This phase I behavior is frequently referred to as the “toe” region on a stress-strain curve.
Beyond this initial phase, the mechanical behavior of skin is primarily dominated by the

Figure 1. Histological analysis of each skin layer. Areas of cellularity and structural
variation can be seen each each of the three layers (A-C). High collagen content and its
disorganized structure can be seen in D-F. Elastin’s orientation can be seen in the crosssectional view, particularly in the epidermis (G) and dermis (H). Scale bar = 200 μm.

behavior of collagen (Corr et al. 2011, Holzapfel et al. 2000). This is illustrated in the
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second phase, in which elastic behavior is observed and the stress-strain relationship is
mostly linear. In this phase, the crimped collagen I fibers are stretched and straightened,
aided in part by lubrication from proteoglycans (Holzapfel et al. 2000, Corr et al. 2011).
As the collagen fibers are merely reoriented and not deformed, they will resume their
original, crimped form if the stress is removed, exhibiting elastic behavior. Finally, in the
third and final phase, collagen fibers are stretched, deformed and eventually break and
slide past each other (Holzapfel et al. 2000). This is the plastic deformation region and it
concludes when the collagen fibers break, signifying failure strength has been reached.
All of this behavior is captured in Figure 2.
While this behavior is very consistent in uninjured skin samples, it is largely
unknown how mechanical interventions, such as suturing may affect this behavior. The
vast majority of skin mechanics studies involve computer models, xenografts, or both
(Chanda et al. 2016, Levi et al. 2016, Capek et al. 2012). The few studies that have
investigated suture mechanics in human skin have done so in vivo, which clearly limits
the mechanical parameters that can be applied. As patient consent and comfort much be
considered in in vivo work, these studies are limited to low tensile loads and strains, it is
unlikely that they encompass the full mechanical behavior of sutured skin that a patient
could experience. For example, one such study limits the tensile strain to 5%, which is
well below the failure strain of intact human skin, which has been reported to be as high
as 115% (Levi et al. 2016, Holzapfel et al. 2000). It is therefore highly likely that the
reported mechanical behavior in such studies are restricted to the viscoelastic toe region
of skin’s stress-strain curve (Figure 2). However, skin is not limited to 5% strain in day-to-
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day activities and therefore this information cannot be considered sufficient to
characterize the full range of tensile mechanics of skin.
Sutures are perhaps the most commonly used and most basic mechanical
intervention in regenerative medicine. While numerous materials are used for sutures, as
a general rule, they have relatively high stiffness and strength, in the range of 5-50 GPa
(Greenwald et al. 1994). It is unclear how sutures affect skin mechanics, as there is little
to no research on the topic. As the skin’s function is dependent upon its integrity, it is
highly important that we understand how suturing affects the integrity, and therefore
function, of skin. While numerous attempts at creating synthetic skin and computer
models have been attempted, accurate information is still lacking (Chanda et al. 2016,
Capek et al. 2012). Therefore, part of
this body of work will focus on how
sutures affect skin mechanics.
Biomechanics

of

the

Meniscus and Cell Development
Like the skin, the meniscus is
a

complex

tissue

designed

to

withstand a range of forces that
occur

in

everyday

movements.

Unlike skin however, the meniscus

Figure 2. Diagram showing collagen I fiber
conformation relative to stress-strain behavior.
Phase I (“toe region”) minimally affects collagen
fibers. Phase II shows the transition from viscous to
elastic behavior. Phase III shows the purely elastic

does not self-heal, even with the
region leading to the plastic region (Holzapfel 2000).

assistance of basic interventions,
such as sutures. Meniscal injuries are among the most common knee injuries
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experienced by children and adults in the United States (McDermott et al. 2008, Malcris
et al. 2004, Buma et al. 2004, Baker et al. 2009, Thambyah et al. 2006, Pteri et al. 2012).
The meniscus is a disc-shaped tissue that lies on the surface of the tibial plateau in direct
contact with the femoral condyles (McDermott et al. 2008, Malcris et al. 2004, Buma et
al. 2004, Baker et al. 2009, Thambyah et al. 2006). The meniscus is a connective tissue
that helps bear and distribute loads experienced by the knee during physical activity,
preserving the tibial articular cartilage underneath. Injuries to the meniscus generally take
the form of an abrasion or a tear and most commonly occurs during a rapid, dynamic
movement in which torsion is applied to the meniscal surface (McDermott et al. 2008).
Limited vasculature and exposure to high loads prevent native tissue from self-healing
and current treatments are mainly restricted to partial or complete menisectomies
(meniscus removal), which put the patient at very high risk for degeneration of articular
cartilage and osteoarthritis (McDermott et al. 2008, Malcris et al. 2004, Buma et al. 2004,
Baker et al. 2009, Thambyah et al. 2006, Son et al. 2013). Damage of the meniscus leads
to increased compressive and tensile stresses on the articular cartilage and often leads
to premature osteoarthritis and possible joint replacement (Buma et al. 2004). For this
reason, a treatment beyond menisectomy is required. Biomaterial and tissue engineering
strategies have been proposed for both repair and replacement of damaged meniscus
tissue, but have so far failed to address the intricacies of this complex tissue. Biomaterial
strategies have looked at allografts, natural scaffolds, and polymer-based synthetic
replacements, all of which have their advantages and disadvantages. The meniscus has
also been studied for possible tissue engineering solutions, with a major focus on
identifying a cell source to produce adequate extracellular matrix to perform the
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mechanical tasks required of this tissue. This review will address the characterization of
the physiology and function of the native tissue and describe some of the current
techniques and research aimed at addressing additional treatments beyond
menisectomy.
Anatomy and Physiology

Figure 3. Diagram showing zones of the meniscus (McDermott et al. 2008)

The meniscus is a highly specific tissue, responsible for bearing and redistributing
loads across the knee (McDermott et al. 2008, Makris et al. 2004, Son et al. 2013). On
multiple levels, the meniscus can be divided into regions based on physiology and
function. On a macroscopic level, the meniscus can be divided into three regions based
on vasculature, with the greatest vasculature, “red zone”, developing in the most lateral
third of the meniscus (Makris et al. 2004, Buma et al. 2004, Son et al. 2013). Moving
medially, the next region is a semi-vascular region commonly referred to as the red-white
zone. The inner third is almost completely avascular and is known as the white zone. All
of this is visually described in Figure 3. Damage to the outer, vascular, red zone tissue
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can self-heal, but damage to the inner red-white or white avascular areas is generally
stagnant due to the limited blood and nutrient supply (Makris et al. 2004, Buma et al.
2004). This limited vasculature is something of a double-edged sword as it indicates that
establishing vasculature is not a major obstacle for tissue engineering strategies, as is
almost always the case with other tissues, however the body’s capacity to heal is the
cornerstone of tissue engineering and regenerative medicine.
Beyond the vasculature, the meniscus structure is highly complex, consisting of
two distinct regions of collagen fiber arrangement. The outer third shows circumferentially
oriented collagen fibers, primarily collagen I, and experiences mostly tensile deformation
under loading. These fibers help conserve the meniscus shape and contribute to resisting
deformation due to the high mechanical loads (McDermott et al. 2008, Makris et al. 2004).
Conversely, the inner two thirds of the meniscus display radially oriented collagen I and
II fibers and experiences mainly compressive deformation under loading. These collagen
fibers are accompanied by a high concentration of proteoglycans that contribute to the
region’s compressive stiffness through water retention (McDermott et al. 2008, Makris et
al. 2004, Nishimuta et al. 2012). This complex 3D extracellular matrix structure is
designed to withstand high cyclic loads. The tissue itself is composed of a gradient of
cells that exhibit a mixed phenotype, with characteristics similar to cartilage and ligament.
These cells are commonly called fibrochondrocytes (McDermott et al. 2008, Makris et al.
2004, Buma et al. 2004, Son et al. 2013, Kun et al. 2012, Nishimuta et al. 2012). As would
be expected, meniscal cells secrete a variety of extracellular matrix proteins, including
collagens I and II, versican, aggrecan, and other glycosaminoglycans and proteoglycans.
Cells in the outer region have a fibroblast-like morphology and show increased expression
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of collagen I and versican (McDermott et al. 2008, Makris et al. 2004, Buma et al. 2004).
Cells in the inner region have a rounded morphology and behave more like chondrocytes
including aggrecan and collagen II (McDermott et al. 2008, Makris et al. 2004). The
cellular expression and distribution contribute to a meniscus that is 72% water and 28%
organic matrix (Makris et al. 2004). Of this 28%, collagen makes up the majority (75%),
then GAGs (17%), the remaining consists of cells, adhesion glycoproteins, and elastin
(Makris et al. 2004). The location and population of meniscal cells, proteins, and collagens
in the meniscus are critical to its mechanical function. Also of note are the anchoring
ligaments that help hold the meniscus in place. The anterior intermeniscal ligament
connects the anterior horns of the medial and lateral meniscus, forcing these two
seemingly separate tissues to act as one (McDermott et al. 2008, Makris et al. 2004). All
of these physiological features contribute directly to the mechanical integrity of the tissue
and ultimately, the knee itself.
Stem Cells in Meniscus Tissue Engineering
When native tissues are incapable of providing adequate cell populations for
treatments, researchers look to other donor sources and autologous stem cell sources.
When dealing with connective tissues, such as the meniscus, there are several
autologous stem cell sources. While human embryonic stem cells (hESCs) remain the
gold standard for any stem cell-based therapy, meniscus tissue engineering strategies
have often used mesenchymal stem cells (MSCs), generally from bone marrow, although
adipose-derived stem cells (ASCs) have been gaining traction due to ease of harvest and
patient compliance (Makris et al. 2004, Baptista et al. 2013, Kokai et al. 2014, Pak et al.
2014). MSCs have been shown to readily differentiate to various connective tissues,
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including fibroblasts and chondrocytes, although a definitive differentiation protocol to the
hybrid fibrochondrocyte phenotype has yet to be established. Similarly, ASCs have been
shown to be capable of differentiating to cartilage and fibroblasts, with evidence
suggesting that meniscus cells, or meniscus-like cells, also being very possible (Kokai et
al. 2014). Many of these studies have provided much evidence to support that use of
certain growth factors used in chondrogenesis, such as TGF-β, can induce expression of
GAGs and biglycans in meniscal cells and MSCs in culture (Buma et al. 2004). Less wellknown, platelet-derived growth factor (PDGF) has shown to counteract production of αsmooth muscle actin, which is often stimulated by TGF-β (Buma et al. 2004). Smooth
muscle actin is a key indicator of scar tissue formation and can cause contraction of the
scaffold, often as great as 50%, which is unacceptable for a tissue construct dependent
upon its structure to fulfill its function (Buma et al. 2004). One of the more interesting
findings is that culturing ASCs in chondrogenic media can yield cells with the same gene
expression of Sox9, aggrecan, and collagen II as cartilage progenitor cells in the same
media (Baptista et al. 2013). This indicates an unprecedented affinity for ASC
differentiation to a cartilage-like phenotype and gives a strong basis for cartilage and
meniscus tissue engineering techniques involving ASCs.
Beyond biochemical factors, mechanical stimulation of stem cells can encourage
differentiation, especially to cell types that typically undergo high and/or cyclic loading
conditions, such as muscle, ligament, bone, and cardiac tissue (Park et al. 2013). While
the exact pathways are unknown, it is understood that transduction of mechanical signals
are responsible for the up regulation of these proteins in the cell (Schwartz et al. 2013).
During development, these mechanical stimuli can be the result of external forces on the
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embryo, or forces generated from differences in tissue growth rates and/or early
contraction of developing muscle and neural tissue (Schwartz et al. 2013). In fact,
restricting movement in developing chick embryos results in malformation of bone and
limited formation of cartilage and other connective tissues (Schwartz et al. 2013, Mikic et
al. 2000). It is also known that mechanical forces are required for proper development of
non-mechanical tissues such as the vasculature, kidneys, and lungs, supporting the need
to investigate stem cell differentiation techniques beyond biochemical factors (Schwartz
et al. 2013).
One of the more thoroughly studied effects of tensile strain is its effects on the
TGF-β pathway (Meier et al 2016, Li et al 2010). An illustration of the mechanism can be
viewed in Figure 4. Activation of this pathway results in activation of numerous key
transcription factors within the cell (stem cell or adult cell), leading to changes in gene
transcription and, often, phenotype in the case of stem cells (Li et al 2010). Activation of
TGF-β pathway is crucial for differentiation of fibroblasts, chondrocytes, and osteocytes
(Li et al 2010, Khani et al 2014, Saha et al 2008). Specifically, activation of TGF-β pathway
leads to up regulation of collagen I and versican (Li et al 2010, Khani et al 2014). Uniaxial
tension has also been shown to align F- actin and other skeletal components, increasing
the elastic modulus of the cell and altering its transcription pathways (Khani et al 2014,
Teramura et al 2012). Importantly, tensile strain applied to stem cells has been shown to
inhibit certain differentiation pathways, particularly adipogenesis (Sen et al 2011). This is
achieved through changes in the cytoskeleton which not only increase stiffness of the
cell, but increase focal adhesions, which also affect the cell’s transcription pathways
(Teramura et al 20102, Sen et al 201). Additional focal adhesions make the cell
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increasingly sensitive to tensile strain, effectively initiating a feed-forward mechanism
towards differentiation to a musculoskeletal phenotype, such as fibroblasts, osteocytes,
or skeletal muscle (Sen et al 2011). The specific differentiation pathway is dependent
upon other factors in the cells’ environment at the time of applied tension.
Numerous studies have shown that substrate stiffness can direct stem cell
morphology, with softer substrates encouraging a more rounded morphology in MSCs
and harder substrates directing cells towards elongation (Galie et al. 2013, Cheung et al.
2009, Lam et al. 2009). Healthy chondrocytes in the knee in vivo are generally subjected
to repetitive cyclic loads of 3-20MPa, which can encourage increased expression of

Figure 4. Diagram of how substrate stiffness and applied tension result in activation
of TGF-β pathway. Expressed proteins act to resist applied tension (Wells et al. 2008).
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GAGs and collagen II (Buma et al. 2004). Similar stimulation can affect differentiation of
MSCs, especially in the presence of chondrogenic media including TGF-β (Petri et al.
2012, Kun et al. 2012, Nishimuta et al. 2012, Baptista et al. 2013, Buma et al. 2004).
Fibroblasts can similarly be obtained, generally through tensile strains of 10-20% (Buma
et al. 2004). It stands to reason then, that combinations of these growth factors and
mechanical stimulation techniques could encourage features of both fibroblasts and
chondrocytes in MSCs. It should be noted that the term mechanical stimulation can apply
to a wide range of techniques and magnitudes of stimulation. One such study looked at
combining continuous perfusion with 8 hours of cyclic compression. MSCs seeded on a
collagen I fibrous scaffold were exposed to perfusion with chondrogenic media, perfusion
with compression, or no stimulation at all. Compressive modulus of scaffolds that
underwent perfusion and mechanical stimulation doubled that of the control group (24.7
kPa and 12.3 kPa, respectively). A significant increase in the rate of production of matrix
proteins was also observed, yet levels were well below that of native tissue. It is also
important to note that even the highest compression modulus is still a far cry from the
native modulus, about 400 kPa, partially due to the relatively low compressive modulus
of collagen I and limited time allowed for cells to replicate and produce matrix (10 days)
(Petri et al. 2012, Lam et al. 2009). Another example of mechanical stimulation used
MSCs with a fibrin and alginate hydrogel. By varying the concentrations of each
component, researchers were able to control the differentiation and scaffold
characteristics. Fibrin helps maintain gel extensibility and encouraged cell proliferation.
Alginate encourages expression of chondrogenic genes, such as Sox 9 and Aggrecan,
as well as production of collagen II and GAGs (Kun et al. 2012). It also resists the
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contraction and shrinking of fibrin, although it is generally brittle and can tear easily (Kun
et al. 2012). Based on previous work demonstrating that tensile strain increases GAG
and collagen population, 1 week was found to be appropriate duration for tensile loading
for optimal expression of key meniscus genes in the fibrin-alginate gel. Through
measuring mechanical and biochemical properties and gene expression, they determined
that a 40:8 ratio of fibrin to alginate had the best combination of net effects and would be
the best composition of the two for future applications (Kun et al. 2012). This study is one
of the few that combines that benefits of stem cells and adjustable materials with
mechanical stimulation, an approach which will most likely be required in a long-term
clinical solution. A third study looked at the effect of strain rates on healthy cartilage and
meniscus explants to compare published effects of strain on developing cells and reaction
of healthy cells. Cartilage and meniscus explants were subjected to several compressive
strain rates (0.5%/s, 5%/s, and 50%/s) and tested for metabolic activity, water, and GAGs.
Total strain was 40% for all strain rates. At the higher loading rates, cells began to lysis
and no significant GAG increase was observed for any of the strain rates (Nishimuta et
al. 2012). This is to be expected as normal strain rates for healthy adults is generally 1921% (Chia et al. 2008). Loading beyond 25% strain can cause permanent deformation
due to the tissue’s inability to achieve full hysteresis (Chia et al 2008). This indicates that
relatively higher strains than in vivo may be necessary for full differentiation in vitro.
Myocardial Infarction Injury and Wound Healing
When considering the role of mechanics in physiology, it is impossible to overlook
the cardiovascular system, in which the heart serves as a pump to circulate blood
throughout the body. One of the more detrimental injuries to this system is myocardial
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infarction (MI), which can lead to heart failure and death (Zhang et al. 2015). Like the
meniscus, the heart has limited capacity to heal. Unlike meniscus, but similar to skin,
relatively simple mechanical interventions can vastly improve long term outcomes. MI
occurs when an occlusion is formed in a coronary artery, restricting blood flow to a region
of cardiac tissue. An illustration of this can be seen in Figure 5A. The induced ischemia
results in localized cell and tissue death, with a resulting scar tissue forming over the
injured area (Olivetti et al. 1990). This layer of scar tissue is stiff and exerts additional
forces on the surrounding, surviving, myocytes as the ventricle contracts and distends.
This cyclic tensile strain results in a condition sometimes referred to as tissue “slippage”,
in which the surrounding tissue is stretched and the scar tissue is thinned. Initial slippage
can occur as early as a few days after the initial infarct (Olivetti et al. 1990). This tissue
A
B

Figure 5. Myocardial infarction and post-infarct remodeling. (A) Myocardial infarction (MI)
occurs when a coronary artery is obstructed (1). The ischemia results in tissue death (2) (Wan et
al. 2013). (B) Images showing infarcted rat heart (left), two patch treatments (middle), compared
to healthy tissue (right) (Wan et al. 2016).

remodeling increases the total volume of the ventricle while decreasing contractility of
surviving myocytes (Olivetti et al. 1990) In rare cases, this can lead to scar rupture, but
more frequently leads to long-term remodeling and complications, such as heart failure.
A visual representation of this process can be seen in Figure 5B.
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The formation of this scar tissue and its mechanical properties are the key to
determining long term prognosis (Wan et al. 2013, Zhang et al. 2015). Tissue remodeling
of the infarct area is dependent upon local inflammatory response, with “normal” healing
resulting in a thin layer of scar tissue that cannot properly resist the wall pressure and will
eventually distend (Zhang et al. 2015). If the scar does not provide resistance to these
high pressures, it will increase wall stress on the surrounding tissue. Increased wall stress
can affect cell metabolic processes, which leads to increases in the dysfunction and
remodeling in the area (Zhang et al. 2015). The resulting complex tissue remodeling is
dependent upon local and systemic inflammation and excessive inflammatory response
can result in poor remodeling that increases the risk of development of heart failure (Wan
et al. 2015). However, impeding the inflammation response can result in non-adaptive
fibrosis, which can lead to cardiac rupture (Wan et al. 2015). Clearly this indicates that
the components of the inflammatory response can directly predict patient outcome. A high
level overview of the inflammation response can be seen in Figure 6, along with the follow
written description.
Inflammation Response in MI
Upon the onset of ischemic conditions, hypoxic cardiomyocytes release dangerassociated molecular pattern (DAMP) molecules (Altara 2016, Boag 2016, Feng et al.
2015). This class of molecules include DNA, heat shock proteins, and adenosine
triphosphate, among others (Altara 2016, Feng et al. 2015). The release of these
molecules trigger the complement system cascade and signal neutrophils to the injured
area (Altara 2016, Boag 2016, Feng et al. 2015). DAMPs can activate toll-like receptors
(TLRs) in other cells, leading to cytokine release (Boag 2016, Feng et al. 2015). Damage
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to myocytes also results in release of reactive oxygen species (ROS), which can cause
further direct industry as well as stimulate cytokine release (including TNF-α and IL-1β)
(Frangogiannis 2002, Feng et al. 2015).
Injury to myocytes also activates the complement cascade via release of
mitochondria membrane components that activate C1-C4 of the cascade (Frangogiannis
2002, Feng et al. 2015). Activation of the complement cascade contributes to leukocyte
recruitment (Frangogiannis 2002, Feng et al. 2015). C5a has been shown to be needed
for local monocyte chemotaxis to the injury area (Frangogiannis 2002, Feng et al. 2015).
TNF-α is a known inducer of the cytokine cascade (Frangogiannis 2002). ROS and C5a
are thought to induce Mast cell degranulation (Frangogiannis 2002). ROS can also
promote neutrophil binding to endothelial cells and promote chemotaxis (Frangogiannis
2002).
Ischemic cells also release ROS and trigger release of cytokines, including TNFα, IL-6 (Boag 2016, Frangogiannis 2016). Cytokines released, including TNF-α and IL1β, activate the nuclear factor κβ (NF-κβ) complex (Frangogiannis 2002). TNF-α is
thought to have other roles in inflammation post-MI (Frangogiannis 2002). TNF-α receptor
knockout mice had significantly larger infarcts, greater myocyte necrosis, and reduced
outcome compared to control animals (Frangogiannis 2002). This suggests that TNF-α
may be necessary to promote and complete inflammation, likely due to activation of NFκβ, which is known to be active in inflammation and inflammation-related pathologies
(Lawrence 2009).
Neutrophils in Inflammation
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Along with increased matrix production, these initial inflammatory pathways have
an important role in recruitment of leukocytes to the area. IL-1β importantly acts to
stimulate neutrophil migration into the area (Chen et al. 2013). As the first leukocyte to
“arrive” to an injured area, neutrophils are an excellent indicator of the time progression
of inflammation. Indeed, the beginning of inflammation is marked with a sudden influx of
neutrophils to the area, especially after reperfusion (Stuart et al. 2016). Activation of the
complement cascade, ROS, and TNF-α trigger circulating neutrophils to begin to arrive
at the injury site (Bonaventura 2016, Boag 2016). Upon arrival, chemokines released from
the injury help neutrophils adhere to the endothelial cells in the surrounding blood vessels,
which contract and reduce the number of interendothelial junctions to permit the
neutrophil passage (Bonaventura 2016, Boag 2016).

Upon passage, they release

chemokines, cytokines, inflammatory mediators, and reactive oxidative species (ROS).
Cytokines and chemokines released initially include TNF-α, monocyte chemoattractant
protein-1 (MCP-1), IL-6, IL-2 (Altara 2016, Bonaventura 2016, Stuart 2016). In particular,
TNF-α expression and concentration directly correlates with patient mortality (Feng et al.
2015). Within a few hours, neutrophils are present in the injured area and last for the first
few days of inflammation (Caimi et al. 2015, Stuart et al. 2016). In the injury area,
neutrophils act to phagocytose the injured cell debris (Stuart et al. 2016).
These initial actions lay the groundwork for the overall inflammation process,
particularly influencing ECM turnover and macrophage response and behavior (Altara
2016). After adhesion, neutrophil granules release MMPs, particularly MMP-2, MMP-8,
and MMP-9, enabling neutrophil migration further into the tissue (Altara 2016). Matrix
metalloproteinases (MMPs) are a family of zinc-dependent peptidases that actively cleave
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various ECM proteins (Iyer 2016). MMPs are released by a number of cells in the heart
including cardiomyocytes, macrophages, fibroblasts, neutrophils, and endothelial cells
(Iyer 2016). Of particular importance are collagenases MMP-1 and -8 as well as MMP-2,
which is a gelatinase (Iyer 2016). Once located in the injured area, the neutrophils release
azurophilic granules, which are visible in differential-quick stains, and include serine
proteases and neutrophil elastase (Altara 2016).
Neutrophil population dramatically decreases by day 7 as a result of apoptosis and
phagocytosis. In chronic inflammation, neutrophil population is constantly replenished as
chemokines continue to trigger attraction and migration to the injury area (Altara 2016).
Indeed, neutrophil population post-MI has been identified as a clear predictor of patient
death (Feng et al. 2015). Due to this, neutrophil population is frequently used as a tool to
identify chronic inflammation resulting from high-risk myocardial infarction injury (Altara
2016, Stuart 2016, Feng et al. 2015).
Macrophages in Inflammation
Within the first hours of injury, neutrophils and monocytes are active at the injury
location (Stuart 2016). The monocyte population increases are especially noticeable in
ischemia-reperfusion injuries, in which perfusion occurs in fewer than 90 minutes. In these
cases, circulating cells have direct access to the injury (Boag 2016). Macrophage
response occurs in two phases: local monocytes in the tissue and circulating monocytes
that arrive and differentiate into macrophages around day 3 of inflammation (Altara 2016).
Both localized and circulating monocytes arriving in the injury area differentiate to
macrophages. Macrophages exist in two distinct phenotypes (M1 and M2) (Wan et al.
2015). M1 macrophages are pro-inflammatory, while M2 macrophages are anti-
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inflammatory and may have protective benefits post-remodeling (Wan et al. 2015).
Polarization towards one phenotype or the other is determined, at least partially, by the
inflammatory state of the injury. M1 differentiation is stimulated by high levels of IFN-γ, a
result of the complement pathway, while IL-4 is required for the M2 phenotype (Geissman
et al. 2010, Wan et al. 2015). Monocytes presenting shortly after ischemia differentiate to
M1 phenotype (pro-inflammatory) macrophages, due to the active complement system
and active cytokines. By the third day after injury, the M1 macrophages are the dominant
cell type in the inflammation area (Stuart 2016, Feng et al. 2015). M1 phenotype increases
the inflammatory process by releasing cytokines, including TNF-α, IL-1β, and MMPs
(Altara 2016, Stuart 2016, Wan 2016). M1 macrophages also produce collagenases
including matrix metalloproteinases (MMPs) (Stuart et al. 2016, Feng et al. 2015). This
activity leads to fibroblast production, migration, and ECM degradation (Altara 2016).
Additionally, M1 macrophages phagocytose myocytes and neutrophils, an action that is
thought to trigger M2 (Altara 2016).
Later in the inflammatory phase (approximately day 5 and on) M2 macrophages
are dominant, helping to induce the myofibroblast phenotype in cardiac fibroblasts, in part
due to release of TGF-β (Stuart 2016, Feng et al. 2015). Stimulating myofibroblasts
results in production of extracellular matrix, notably collagen, and scar formation (Stuart
2016). M2 macrophages increase expression of TGF-β1, encouraging the myofibroblast
phenotype in CFs and increase matrix production (Geissman et al. 2010, Wan et al. 2015,
Stuart et al. 2016). M2 macrophages have an anti-inflammatory or inflammation resolution
phenotype, expressing anti-inflammatory markers that encourage collagen synthesis,
myofibroblast phenotype, and angiogenesis (Altara 2016). Inflammation is resolved with
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the activity of the M2 macrophage phenotype, which upregulates TGF-β, IL-10, and profibrotic lipid mediators (Altara 2016). Apoptosis of macrophages indicates the end of the
inflammation phase and beginning of the proliferation phase (Stuart et al. 2016).
Monocyte differentiation to macrophages and dendritic cells can also shed some
light on the long term prognosis in MI. Monocyte-derived macrophages are the
predominant inflammatory cell after approximately three days after injury occurs (Stuart
et al. 2016). It is theorized that ideal wound healing will include a large portion of antiinflammatory M2 macrophages compared to the pro-inflammatory M1 macrophages
(Wan et al. 2015). Reduction in M2 macrophage recruitment, along with lower CD4+ T
cells has been associated with weak, nonfunctional scar formation (Geissman et al. 2010,
Wan et al. 2015). Furthermore, monocytes also possess the capability to differentiate into
fibroblast-like progenitors in environments rich in TGF-β and other factors present with
the M2 macrophage (Feng et al. 2015). Therefore, the domination of the M2 phenotype
may also help increase the scar tissue formation by directing monocyte differentiation
towards a fibroblast-like phenotype (progenitor) (Feng et al. 2015).
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Figure 6. Overview of inflammation process post-MI.
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Cardiac Fibroblasts and Adoption of the Myofibroblast Phenotype
Like all injuries, cardiac ischemia due to myocardial infarction triggers an
inflammatory response that helps process the damaged tissue and promote wound
healing. Cardiac fibroblasts (CFs) play a significant role in directing this inflammatory
response. Unlike their myocyte counterparts, CFs are relatively unharmed by temporary
hypoxic conditions, and therefore generally survive the ischemic incident (Chen et al.
2013, Shinde et al. 2014). CFs are implicated in directly activating the molecular pathways
that stimulate inflammation (inflammasome) (Chen et al. 2013).
As injured cardiomyocytes release DAMPs, they activate toll-like receptors (Boza
2016, Altara 2016). Toll-like receptors (TLRs) are a type of IL-R ligand that can bind
DAMPs, resulting in changes to cellular behavior (Boza 2016, Altara 2016). TLRs are
present on cardiac fibroblasts, and upon binding, ERK1/2 and PI3k-Akt kinases activate
the NF-κβ pathway, resulting in transcription of pro-inflammatory cytokines as well as αsmooth muscle actin (α-SMA) and other genes indicative of the myofibroblast phenotype
(Boza 2016). This activation also triggers activation of the complement pathway and
production of reactive oxidative species (ROS) (Chen et al. 2013). These products have
a very strong effect on cardiac cells in the infarct area, triggering a complex inflammatory
cascade (Chen et al. 2013, Shinde et al. 2014). Both the circulating cytokines and reactive
oxidative species (ROS) can act upon CFs stimulating p38k and ERK1/2 pathways (Chen
et al 2013, Shinde et al 2014, Boza et al 2016). These activated pathways, along with
mechanical stress and exposed fibronectin, act to alter the cells towards an anti-apoptotic,
myofibrotic phenotype, with increased fibrosis and expression of α-SMA (Chen et al.
2013). This new phenotype is only observed in the injured, inflammatory state. The
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metalloproteinases (MMPs) and inhibit production of MMP inhibitors (Chen et al. 2013).
This phenotype is also affected by latent TGF-β from earlier pathways, increasing the
expression and production of matrix proteins, particularly collagen (Chen et al. 2013).
This progression towards the myofibroblast phenotype simultaneously influences,
and is influenced by, neutrophil and macrophage activity. During early inflammation,
cardiac fibroblasts proliferate and migrate into the injured area, where they release MMPs
and inflammatory cytokines to contribute to the inflammatory process, along with
neutrophils (Altara 2016). TGF-β also upregulates TL4, a type of TLR, further encouraging
the myofibroblast phenotype (Boza 2016). Expression of ROS and cytokines contributes
to neutrophil infiltration in the area, while myofibroblast activity influences macrophage
phenotype (Boza 2016, Altara 2016). Approximately three days after injury, cardiac
fibroblasts in the injury area have fully adopted the myofibroblast phenotype, in parallel
with arrival of M2 macrophages (Feng et al. 2015). This phenotype preferentially
expresses TGF-β, α-smooth muscle actin, and collagen I and is responsible for scar
formation and contraction during inflammation and maturation (Altara 2016).
Mechanical stress in the area also contributes to the differentiation to the
myofibroblast phenotype. The increased tension on the cells changes the cytoskeletal
structure of the myofibroblasts (Boza 2016). This tension leads to increases in focal
adhesions, which along with the changes in cytoskeletal structure, leads to increased
expression of collagen (Khani et al 2014, Teramura et al 2012, Boza et al 2016). Collagen
expression continues until the stress experienced by the cell is balanced by the newly
formed collagen scar (Boza et al 2016, Altara et al. 2016). However, if the inflammatory
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process does not progress properly or is not adequately resolved, complications can
occur.
Complications from Improper Inflammation
The inflammatory process in many animals, including humans, has evolved to
place priority on speed of wound closure, rather than regeneration (Godwin 2016). While
this is ideal for limiting infection and other complications, it does prevent complete tissue
regeneration after myocardial infarction. How this inflammatory process unfolds can
directly affect patient outcome post- MI (Boag 2016, Chen et al 2013).
The outcome of inflammation is twofold: clear the injured area of cell and tissue
debris, and produce the biochemical progenitors of fibrosis and angiogenesis
(Bonaventura 2016). In many injuries, including MI, resolution of inflammation occurs
seamlessly. However, unresolved inflammation can result in inadequate or excessive
scar tissue deposition, arrhythmias, and other complications in MI (Altara 2016).
No effective treatment for myocardial ischemia has been identified to date (Boag
2016). Current best practice is to reperfuse the injury as quickly as possible after ischemia
(Boag 2016, Stuart 2016). Reperfusion is achieved through primary percutaneous
coronary intervention (PPCI), which reestablishes blood flow to the area (Boag 2016).
Time is of the essence after onset of ischemia, After 90 minutes of occlusion, capillaries
begin to plug with thrombi and cells (Boag 2016). This is known as microvascular
obstruction, in which perfusion can’t be maintained even though blood flow has been
reestablished (Boag 2016). The accumulated cells also contribute to ROS production and
contribute to inflammation (Boag 2016).
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While reperfusion is generally accepted to improve outcomes, it is not without
additional complications. Injury from reperfusion may be responsible for as much as 50%
of infarct size (Boag 2016, Nah et al. 2009). This is mainly due to “Lethal reperfusion
injury”, in which previously surviving cells die due to the changes in ROS, pH, and
mitochondria collapse (Boag et al. 2016, Nah et al. 2009, Przyklenk et al. 2012, Przyklenk
2014).
T cells can be activated by danger associated molecular patterns (DAMPs) (Boag
2016). T cells help limit infarct size and limit neutrophil and macrophage populations
(Boag 2016). T helper cells also produce IFN-γ and TNF-α and support macrophage
activity. Mice without lymphocytes saw reduced leukocytes in the infarct area, and
reduced injury from reperfusion (Boag 2016, Feng et al. 2015, Nah et al. 2009). Innate
immune cells (neutrophils, monocytes, etc) are thought to play a large role in regulating
inflammation (Boag 2016, Feng et al. 2015). Inadequate macrophage population can
prevent full scar tissue formation, potentially resulting in rupture (Stuart et al. 2016).
Clinically, high neutrophil counts have been linked to a greater risk of mortality (Boag
2016). A reduced lymphocyte population and increased neutrophil population after
reperfusion is a predictor for complications 3 years post-infarct (Boag 2016). The
increased risk associated with high neutrophil populations may be due to the increased
expression of MMPs. Excessive MMPs reduce scar tissue deposition and cross-linking,
resulting in a thinner, weaker scar, which allows for excessive left ventricle dilation
(Voorhees et al. 2015).
In MI without reperfusion, neutrophil population peaked at day 3, macrophages at
day 7 (Boag 2016). With reperfusion, the peaks for leukocytes remained the same
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although overall cell counts were lower (Boag 2016). Neutrophil elastase (NE) is overly
active in chronic inflammation, in part because the α-proteinase inhibitor that would
counteract NE’s activity is itself deactivated by reactive oxidative species (Doring 1994).
Proper regulation of the inflammatory phase is crucial, as inadequate inflammation
can be just as detrimental as excessive inflammation. While inadequate or inappropriate
inflammation can lead to underdeveloped scar tissue, excessive inflammation however,
can lead to overly fibrotic tissue (Stuart et al. 2016). In these cases, scar tissue can extend
well past the injured area, affect mechanical and electrophysiological heart function. This
can lead to arrhythmia or cardiac arrest (Stuart et al. 2016).
Similarly, overactive and underactive leukocyte activity during inflammation can
lead to impaired healing and poor left ventricular remodeling (Stuart et al. 2016, Nah et
al. 2009). This poor remodeling can also result in arrhythmias due to poor
electrophysiological remodeling (Stuart et al. 2016). Therefore, even patients that survive
the initial infarct can be at risk for heart failure or cardiac arrest (Stuart et al. 2016). The
border region of the infarct zone is at the greatest risk for inflammation-induced
arrhythmias, which can affect the surrounding, healthy tissue (Stuart et al. 2016). Over
expression of TNF-α reduces cardiomyocytes’ ability to repolarize, directly affecting
potassium channels (Stuart et al. 2016). It also affects gap junction formation and
conduction velocity by limiting the promoter of the connexin 43 gene, which is responsible
for gap junction formation (Stuart et al. 2016). All of this can lead to arrhythmias.
Excessive fibrosis in the interstitial space of the border zone can also result in
arrhythmias, due to non-conductive collagen (Stuart et al. 2016). Therefore, induction of
an overly fibrotic state post-MI can be as detrimental as under-production of scar tissue.
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It is also important to recognize the role of comorbidities in the inflammatory
response post-MI. Patients experiencing myocardial infarction frequently do so as a result
of coronary artery disease, and often with other high-inflammation pathologies, such as
obesity (Przyklenk 2015). This baseline level of chronic inflammation will clearly influence
the inflammation response in an injury such as MI, and this baseline level of chronic
inflammation is not adequately reflected in most animal models and therefore may
present some difficulty in predicting clinical effects.
Biochemical Inhibition of Inflammation
Numerous over-the-counter anti-inflammatory agents are used daily by millions of
people. One of the most common of these is ibuoprofen. Ibuprofen is a nonsteroidal
antiinflamatory drug (NSAID). All NSAIDs act on cyclooxygenase enzymes, which have
two forms: cyclooxygenase 1 and 2 (COX 1 and COX 2) (Amer et al. 2010, Ong et al.
2013, Kirkby et al. 2016). Due to its effects on the GI tract, many NSAIDs are now
designed to selectively block COX 1, which still enables the majority of the antiinflammatory effects (Kirkby et al. 2016). However, stable presence of COX 2 in the brain
and thymus require limited use of NSAIDs, including ibuprofen (Kirkby et al. 2016,
Patrono 2016).
Ibuprofen blocks the catalytic site from arachidonic acid via acetylation of a serine
residue near the binding site on COX 2, preventing prostaglandin formation (Amer et al.
2010). Prostaglandins are mediators of inflammation (Amer et al. 2010, Giroux et al.
2000). The large acetyl group prevents cleavage of arachidonic acid into PGG2 and
PGH2, which indirectly prevents platelet formation (Amer et al. 2010). This results in
reduced platelet aggregation and inhibits epithelial cell proliferation, both of which are
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desirable for patients at risk for MI. This may be of special importance in situations in
which reperfusion does not occur until 90 minutes or longer post-MI, as previously
addressed.
COX 2 is expressed by cells involved in inflammation, including macrophages,
fibroblasts, or endothelial cells (Giroux et al. 2000). Various cytokines induce COX 2
expression, including interleukins (Giroux et al. 2000). Cyclooxygenases (COX) convert
arachidonic acid to prostaglandins (Giroux 2000). Therefore, synthesis of prostaglandins
is inhibited due to ibuprofen’s inhibition of COX 2 (Ricciotti 2011). Prostaglandins broadly
act on G-protein coupled receptors that could alter the receptor structure and function,
affecting cells’ responses to inflammation (Ricciotti et al. 2011). NSAIDs bind to and
deactivate one of the monomers of the COX 2 dimer (Ricciotti et al. 2011). Ibuprofen
inhibits COX 2 without restricting the NO pathway, which is required for wound healing
(Kirkby et al. 2016).
Inhibition of COX 2 has shown to have negative cardiovascular effects, specifically
increased risks of MI, hypertension, and reduced outcomes of congestive heart failure
(Amer et al. 2010, Kirkby et al. 2016). Because of this, NSAIDs are linked with increased
mortality after MI (Amer et al. 2010). However, a study by Leshnower et. al. showed that
administration of ibuprofen to rabbits and sheep after MI reperfusion did not result in any
significant changes in myocyte apoptosis or infarct size (Leshnower et al. 2006).
Additionally, ibuprofen is thought to induce signaling through NF-κβ pathway, which is
also involved in the inflammation process (Leshnower et al. 2006). Clearly, this shows
that ibuprofen could have a potential benefit in an overly inflammatory state, but may be
counterproductive to normal healing. While ibuprofen, along with other NSAIDs, has been
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suggested to increase risk of subsequent MI after initial MI, ibuprofen is thought to be one
of the lower risk NSAIDs (Ong et al. 2013).
Naproxen (Aleve, Midol) is the only NSAID that has no risk of acute myocardial
infarction (AMI) associated with its use (Vargas-Lorenzo 2013). All other NSAIDs have
approximately the same small increased risk of AMI associated with daily use (VargasLorenzo 2013). However, this risk was analyzed from numerous studies that looked at
high-risk patient groups, which are far more likely to have an adverse event, independent
of NSAID use. Newer research looking specifically at ibuprofen has shown that rats
receiving ibuprofen after MI may have increased integrity in cell membranes, and reduced
ROS release (Patel et al. 2016). This suggests that ibuprofen may have some benefit as
a cardioprotective drug, or at least present less of a risk than other NSAIDs.
A study in which dogs with AMI were given a variety of treatments showed that
infarct expansion was attenuated by ibuprofen six week post-MI (Jugdutt et al. 2007).
NSAIDs can interfere with the healing and inflammatory processes, resulting in less
collagen deposition and net scar thinning (Jugdutt et al. 2007). This is of particular
concern clinically, where pathologies such as hypertension can lead to high intracardiac
pressures, making the infarcted tissue’s mechanical stability even more precarious.
Animals treated with ibuprofen only saw a decrease in mechanical strength of the infarct
area relative to sham, but not a significant decrease relative to infarct only animals
(Jugdutt et al. 2007). No change in distensibility, ejection fraction, or contraction strength
was reported relative to the control group, however a decrease in both collagen I and III
was noted (Jugdutt et al. 2007). Notably, the ratio of type I to type III collagen was
increased, despite this overall drop in collagen production (Jugdutt et al. 2007). These
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results suggest that an NSAID, such as ibuprofen may be of some assistance in a
myocardial infarction treatment in which the mechanical integrity of the infarct area is
assured. Such would be the case in a patch application.
Use of Patches to Increase Mechanical Integrity Post-MI
Post-MI application of a biocompatible patch, with or without stem cells or growth
factors, is one of the most commonly researched treatments in cardiac bioengineering
(Lam et al. 2013, Wendel et al. 2014, Zhang et al. 2015, Tan et al. 2009, Serpooshan et
al. 2013). The premise of the research is that application of a patch to the infarct area
will increase wall thickness and provide mechanical support to the injured region (Zhang
et al 2015, Wan et al 2013, Stuart et al 2016, Wan 2017, Tan et al. 2009). By supporting
the damaged tissue, the wall stress on the remaining tissue is reduced. This prevents
scar bulging during systole as well as preventing excess mechanical strain on
surrounding tissue (Lam et al. 2013, Wendel et al. 2014, Zhang et al. 2015, Wan et al.
2017). Mechanical strain on the surrounding tissue has previously been described to
result in infarct expansion and increase risk of arrhythmia (Stuart et al 2016, D’Amore
2016). Some studies suggest that timely application of the patch can prevent changes in
ejection fraction and other measures of heart function as early as one week after infarct
(Wendel et al. 2014). Furthermore, by reducing the size of the infarct, patch treatments
have also been shown to increase contractility post- MI (Serpooshan et al. 2013).
Along with providing mechanical support, cardiac patch research also investigates
potential uses as a delivery vehicle for cells, growth factors, or medications (Wendel et al
2014, D’Amore et al. 2016, Tan et al. 2009). For this reason, natural and/or degradable
materials are preferentially investigated. However, degradation, particularly of synthetic
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materials, has been cited as a potential risk for chronic inflammation in cardiac patch
applications (D’Amore et al. 2016).
In one study that looked at inflammatory effects, pigs underwent myocardial
infarction surgery and received with a multilaminate urinary bladder-derived ECM patch
(UBM) or expanded polytetrafluoroethylene (ePTFE) patch. Inflammation was reported
as increased in ePTFE compared to UBM, with UBM subjects displaying greater
myofibroblast recruitment and population (Robinson et al. 2005). While this indicates that
a naturally-derived collagen-based patch may result in a better prognosis for the patient,
it doesn’t fully explain how the inflammatory process is affected by a collagen-based
patch. In order to fully understand the implications of a cardiac patch therapy, it is crucial
to understand how these patches affect inflammation post-MI. These questions will be
addressed in Chapter 4.
When treating myocardial infarction, the current clinical goals are to limit scar
expansion, preserve contractility and encourage regeneration (Perea-Gil et al. 2015).
Current approaches involve use of a patch material, either with or without stem cells,
growth factors, or peptides (Perea-Gil et al. 2015, Tan et al. 2009). Collagen-based
patches have been included in numerous studies and have been shown to promote
angiogenesis and limit infarct expansion when administered within hours of MI (Perea-Gil
et al. 2015, Mewhort et al. 2014, Tan et al. 2009, Serpooshan et al. 2013). Importantly,
SIS patches have been used in murine infarct models and shown to increase ejection
fraction by as much as 35% post-MI (Toeg et al. 2013, Perea-Gil et al. 2015). In general,
performance changes are significant at least by 21 days post-infarct in murine models
(Toeg et al. 2013, Voorhees et al. 2015, Tan et al. 2009). However, in the literature
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reviewed, significant performance (i.e. ejection fraction) changes were not noted at day 7
or earlier indicating that these changes occur primarily in early proliferation phase (Toeg
et al. 2013, Voorhees et al. 2015). This is logical, as it is only after inflammation that the
bulk of the scar tissue is formed and full integration of the patch material can take place.
Other murine models utilizing multiple patch models, showed that all tested
patches reduced infarct area size and increased wall thickness 8 weeks after infarct
(D’Aleno 2016). These findings suggest that the mechanical support provided by the
patch can have significant physiological improvements. Furthermore, these patch
materials have shown to retain any seeded cell populations or growth factors better than
synthetic counterparts, suggesting that collagen-based patches may be especially
beneficial in future tissue engineering applications (Perea-Gil et al. 2015, Mewhort et al.
2014).
While there is a great deal of research to support the mechanical efficacy of this
treatment, it is relatively unknown how patches directly affect the inflammatory process
(Zhang et al. 2015, Wan et al. 2017). What work that has been done has focused on
identifying risk of long-term chronic inflammation, and almost exclusively for synthetic
patches (D’Amore et al. 2016). This suggests a large gap in literature as it is apparent
from the literature that modifications to the inflammation process can greatly increase or
decrease the risk for arrhythmias, rupture, or other complications. It is also well
established that collagen-based patches provide excellent mechanical support,
consistently increasing left ventricular wall thickness and reducing infarct size in both
porcine and murine models (D’Amore et al. 2016, Zhang et al 2015, Perea-Gil et al. 2015,
Lister et al. 2016). Natural materials, including SIS are decellularized before use, using a
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combination of chemical and mechanical treatments that are generally proprietary.
Despite these treatments, actual confirmation of removal of immunogeneic material is not
conducted for SIS (Lam et al. 2009, Wu et al. 2012, Shahabiour et al. 2016, Sutherland
et al. 2015). As there have not been many reports of rejection, it is a relatively safe
assumption that any remaining immunogeneic material is not enough to cause rejection.
However, even small amounts of such material can alter the inflammation response (Beck
et al. 2016, Sutherland et al. 2015). It is therefore prudent to investigate how these
patches, such as the commonly used porcine SIS patch, affect inflammation.
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Introduction
Skin acts as a physical barrier between the internal body and the environment.
Part of this role includes maintenance of tissue integrity while facilitating and responding
to movement, which requires a range of viscoelastic material properties. Like many
tissues, skin’s mechanical behavior is dependent upon the arrangement and composition
of extracellular matrix (ECM). ECM composition of skin varies not only between species,
but based on age, gender, size, and location on the human body as well (Edwards et al.,
1995, Firooz et al. 2016, Zhu et al. 2015, Zollner et al. 2013). Due to this variation, it has
been difficult to fully characterize the mechanics of skin. The few studies that have been
performed with human skin in vitro were performed at very low strain rates in the range
of 2-20 mm/min (Blackmore et al. 2014, Grady et al., 2009, Miller et al., 2000). Even within
this narrow range of applied strains, large variation has been noted between properties,
with elastic moduli reportedly ranging from 5-30 N/mm2 and ultimate strains from 35115%, although some of this variation is attributed to differences in age of the samples
(Blackmore et al. 2014, Edwards et al., 1995).
Additionally, while the mechanical properties of sutures have been investigated, to
our knowledge, no study has investigated how the mechanics of sutured skin compare to
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those of normal skin, beyond the microscale (Flynn et al., 2010, Vesentini et al., 2003,
Wang et al., 2014). Such information is critical for understanding how suturing changes
the biomechanics of skin, when suturing would be considered appropriate relative to the
numerous alternatives being studied in the field, and how suturing may affect other,
similar soft tissues that may not be as easily tested, such as the meniscus. Most
immediately, this information might be particularly important to patients who are athletes,
or otherwise committed to an active lifestyle, or for patients that require physical therapy
after a surgery or other injury. For these patients, it is highly important that the mechanical
effects of sutures on skin are known at a macroscopic level, especially if it leads to
increased risk of further injury. Currently, there is not information readily available about
how sutured skin behavior may differ based on the strain rate and orientation of the injury
relative to the direction of movement. Here, we investigated the tensile properties of
human skin that was injured, sutured and then mechanically stretched at low (2 mm/min)
and high strain (100 mm/min) rates. These loading rates were selected to encompass the
range of loading human skin would be expected to withstand during a range of common
movements, such as walking or stretching (Blackmore et al 2014). Our hypothesis is that
if skin is injured with a linear, full thickness injury, sutured and stretched 90º to and in-line
with the injury, then elastic modulus will increase relative to intact skin, due to the high
stiffness of the suture material. Furthermore, it is anticipated that fracture strength and
failure strain will decrease, due to the stress concentration around the skin at the bite
points. Additionally, we hypothesize that these differences will be more pronounced in the
high strain group, both between strain applications and within groups.
Materials and Methods
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Human tissue procurement was obtained in accordance with the Wayne State
University Institutional Review Board Protocol #054514M1E. Skin samples were donated
from patients undergoing abdominoplasty at
Henry Ford Health System (Detroit, MI) with no
known diseases. Skin from 17 Caucasian
female patients aged 39-52 were utilized.
Patient age and sex were selected based on
sample availability and predicted variations due
to age and sex (Zollner et al. 2013). Male and
non-Caucasian skin samples were excluded
due to inadequate sample numbers and
potential
Table 1. Patient data for skin use.

mechanical

differences

between

demographic groups (Edwards et al., 1995,
Firooz et al. 2016, Zhu et al. 2015, Zollner et al.

2013). Patient data can be viewed in Table 1. All samples were taken from the abdomen,
although exact location and orientation of bulk skin samples relative to the patient were
unknown and therefore considered to be random. Tissue samples were received on ice
and subcutaneous fat was removed using surgical scissors. Skin samples for baseline
testing were cut to approximately 65 mm x 10 mm pieces, with three samples per patient
sample prepared to account for any variation or slippage during testing. Skin samples
that were to be sutured were cut to approximately 65 x 60 mm pieces. A scalpel was used
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to apply a 40 mm incision. Incisions were sutured using a simple, interrupted suture with
6-0 Ethicon Prolene® sutures placed every 5-7 mm, per reported optimal suture spacing
for the skin location and suture type (Vesentini et al. 2003). Orientation was defined as

Figure 7. Installation of tissue sample in Instron. (A) Skin samples (red arrow) are
clamped into tensile device using serrated clamps (green arrow) and measured before
stretching. (B) Schematic of the suturing patterns (left – perpendicular orientation; right –
parallel orientation).

the orientation of the injury, or “cut”, to the axis of applied tension. Sample orientation
would be either 90º to the injury or in-line with the injury line. Illustration of this definition
can be seen in Figure 6. Following suturing, all samples were stored in phosphate
buffered saline (PBS) at 4oC until testing.
Tensile testing was conducted on either an Instron 5943 (low strain) or Instron
5984 (high strain) with BlueHill 3 software (Instron, Norwood, MA). Tensile testing was
performed at two strain rates: 2 mm/min and 100 mm/min. Samples were installed in the
Instron as shown in Figure 7. Prior to testing, each sample was adjusted and measured
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for consistency. Following installation, samples were submerged in a PBS bath during
testing to provide adequate tissue hydration. During testing analysis, failure mode in
samples with sutures was defined as the first instance of failure of any individual suture.
Similarly, intact skin was considered to have failed when a visible tear was able to
significantly affect the applied stress as indicated by the BlueHill software during testing.
Patient samples for the control, 90º, and in-line groups were n=7, n=6, and n=6,
respectively. Again, each sample number consisted of three individual tissue pieces from
the same donor, each tested separately to account for variations in location or installation
in the Instron. All were included in data analysis unless noticeable slippage at the grips
occurred, in which case the individual piece would not be counted toward the sample
average. Tensile mechanics at the same strain rate (ex. 2 mm/min or 100 mm/min) were
compared using one-way ANOVA with Tukey post-hoc with p < 0.05 for significance.
Results from the power analysis yielded a β of 86.4, based on the differences from the
elastic modulus calculations. This indicates that the sample size is adequate for this work.
All statistics were calculated using SPSS.
Stress relaxation testing was also conducted. Samples were prepared to the same
dimension and suture patterns as with tensile testing. Samples were placed in the Instron
5943 using serrated clamps and stretched to 80% of maximum strain at a rate of 2
mm/min. Maximum strain was determined from the tensile testing results at 2 mm/min.
Once 80% of maximum strain was achieved, the strain gauge length was held constant
for 5 min, with changes in applied stress recorded (Saulis et al., 2002). Five minutes has
been used as a hold length in skin mechanical testing previously, and thus is appropriate
for comparison between published results (Saulis et al. 2002, Blackmore et al. 2014).
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Results were expressed as average percentage decrease in stress, rather than absolute
stress, to normalize the data. Recorded decreases in stress were averaged for each of
the three groups: intact (control), samples stretched 90º to injury, and samples stretched
in-line with injury. Percent changes in stress between groups were compared using oneway ANOVA with Tukey post-hoc.
Results
Initial testing of intact skin samples at 2 mm/min, showed that human abdominal
skin has an average elastic modulus of 7.76 MPa. At 100 mm/min, measured modulus
significantly increased more than threefold to 29.1 MPa (p = 0.0001). However, these
results fit within the range of 5-30 MPa commonly cited as the range for adult human skin,
which illustrates the variation in reported data (Edwards et al., 1995, Blackstone et al.
2014). These two data sets were compared using a student’s t test to illustrate the range
in reported data.
Interestingly, the elastic modulus at higher strain rates reflects that of other
materials that consist primarily of collagen I, such as porcine small intestine submucosa
(SIS) (Roeder et al., 1999). This suggests that at higher strains, collagen I is the primary
component bearing the load, while other components, such as elastin, have a greater
impact on mechanical properties at lower strain rates. Such assessments can be based
on the high stiffness and nearly perfectly elastic behavior of collagen, which is significantly
higher than elastin or proteoglycans. This is also supported by the lack of plastic
deformation under 100 mm/min strain, whereas a small region of plastic deformation was
observed at 2 mm/min strain as shown in Figure 8. Samples with sutures had elastic
moduli almost double that of intact skin at low strains as shown in Figure 8 and Table 1.
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This is likely due to a level of stress off-loading by the stronger, stiffer suture material,
protecting areas of skin from experiencing the full applied stress before the stress
concentration at the bite location overwhelmed the tissue. At higher strains, skin samples
stretched 90º to the injury had insignificant differences in elastic modulus measurements
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as the control group (29.1 MPa), while recorded moduli for the samples stretched in-line
with the injury had a significant increase to approximately 39 MPa (p = 0.0001). This is
likely a result of the additive mechanical properties of the sutures, as well as an effect of
unbroken collagen filaments in the tensile axis. Fracture strength also saw a large

Figure 8. Tensile behavior of skin under low and high strain rates. Graph shows skin
under 2 mm/min strain (A) and 100 mm/min (B). Lower strain resulted in lower elastic
modulus (slope of the fitted line) and exhibited slight plastic deformation. Failure strains, or
maximum strain achieved before failure, were noted to be lower at higher strain rates.
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increase between the strain rate groups, an observation similar to the elastic moduli.
Again, this suggests that at the higher strain rates, the mechanical behavior of collagen
is dominant.
Failure strain averaged 81.54% at 2 mm/min, which falls within the age-dependent
range of 35-115% strain before failure (Edwards et al., 1995). However, at 100 mm/mm,
failure strain was found to average only 44.5%. The lower failure strain may be due to
high strain rates’ limiting collagen fibers to straighten and align before being exposed to
higher levels of stress, resulting in failure at lower strains. While failure strain of the human
skin samples was found to be greater when stretched at 2 mm/min, the relationship
between the failure strains at each speed was found to be similar in the control (intact)
and 90º groups. Both groups saw a decrease in failure strain when the strain rate
increased from 2 mm/min to 100 mm/min. Samples stretched with the injury in-line with
the tensile axis, however, only displayed a decrease of approximately 23% with the
increase in strain rate. However, the failure strains were markedly lower in the in-line
group, with failure occurring at 46.8% strain at 2 mm/min and 36.2% strain at 100 mm/min.
Interestingly, the failure strains for both sutured groups at 100 mm/min are nearly
identical, with failure occurring around 35% strain, regardless of suture orientation (90º to
or in-line with the injury). Differences in failure strain at 2 mm/min were found to be
significant, between control and 90º to the injury (p = 0.0073), or in-line with the injury (p
= 0.001), and between the two suture groups (p = 0.0057). At 100 mm/min, none of the
differences between treatment groups were statistically significant. This suggests that the
generation of stress points created by the suturing process may result in early failure of
sutured skin at high strain rates. The comparatively higher forces during the high strain

45

rate may circumvent the viscous behavior of skin. This could lead to more rapid tearing
of the skin, thus resulting in undesired failure at lower strains. A summary of these results

Table 2. Summary of tensile properties of skin samples without sutures, and with
perpendicular and parallel oriented sutures. * Indicates statistical significance within strain
rates (p <0.05).

can be found in Table 2.
Overall, the strain rate had a statistically significant impact on elastic modulus,
fracture strength and strain at failure. The elastic modulus was significantly impacted by
orientation, either 90º to the injury, or in-line with the injury, when stretched at 2 mm/min
(p=0.003 between control and 90º and p= 0.001 between control and in-line), however at
100 mm/min significance was only observed for skin stretched in-line with the injury (p=
0.001). Similarly for fracture strength, only samples stretched in-line with the injury had a
significant difference at both strain rates (p = 0.0127 at 2 mm/ min and p = 0.002 at 100
mm/min).
To test stress relaxation, samples were held under constant load and changes in
stress over time were recorded. Stress relaxation testing showed relatively consistent
relaxation proportional to the initial applied stress to achieve 80% strain as shown in
Figure 9. However, due to the differences in stiffness at lower strain rates, the net stress
relaxation varied between groups slightly, with samples stretched in-line with the injury
having the greatest net stress relaxation, but a slightly lower proportional relaxation (39%)
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than samples stretched 90º to the sutured injury (42%). However, none of the differences
were significant. These stress relaxation values are slightly greater than the results
published by Saulis et al., although this may be due to differences in sources of skin, as
well as age and gender variations, as the cited work investigated forearm skin flaps of
multiple ethnicities.
Discussion
When skin is sutured, a high-tensile strength material is used to bear tensile loads
applied to the skin (Wang et al., 2014). Suturing requires induction of micro and macro
tears in the surrounding tissue, creating major failure points as observed during tensile
testing (Flynn 2010). Additionally, these tears are subjected to forces averaging 0.5 N1.5 N required to pull the injury closed, further exacerbating the damage inflicted during
needle driving (Capek et al. 2012). Samples with sutured injury in-line with the tensile axis
had the highest average fracture strength of 4.86 MPa, compared with intact samples and
sutured samples stretched 90º to the injury, which had fracture strengths of 3.77 MPa and
3.54 MPa, respectively. Samples stretched in-line with the injury had the highest fracture
strength of all groups at 100 mm/min, with a fracture strength of 11.5 MPa. Additionally,
stretching sutured skin in-line with injury seemed to disrupt the viscous region of the
stress-strain curve, most notably at 2 mm/min. Such samples only reached 13.2% strain
before displaying elastic behavior. This is a noticeable decrease from the samples
stretched 90º to the injury (26.9%) and the intact skin groups (30.8%). Differences at 100
mm/min were much less noticeable, with all samples displaying strains in the range of 1317% before experiencing elastic behavior. This is of particular interest considering the
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abdomen’s highly elastic behavior relative to other areas of skin, such as the head or
limbs (Blackstone et al. 2014).
While loading conditions in vivo are rarely uniaxial, uniaxial testing is appropriate
as a preliminary analysis of mechanical properties as it is more consistently and more
frequently performed on soft tissues (Blackstone et al. 2014, Zhu et al. 2015, Zollner et
al. 2013). In situations where loading is considered to be mainly, if not entirely, uniaxial,
other approaches have been taken to reduce stress concentration around each individual
bite. While simple, interrupted sutures are frequently used for closing superficial wounds,
a suture button with figure 8 suture pattern has been used with great success in reducing
stress concentration in patellar tendon repair (Otsubo 2016). This methodology did not
restrict range of motion and yielded a 98% success rate (Otsubo 2016). Additionally,
procedures such as anastomosis involve suturing of soft tissues that are very similar to
skin (i.e. adventitia) and these tissues experience uniaxial loading, especially during the
procedure (Roussis 2015).
Polypropylene (Prolene®) is a stiff and strong material, with an average elastic
modulus of 100 MPa (Greenwald et al., 1994; Chu et al., 1989). Prolene® has a tensile
strength of 40 GPa, and only minimally decreases after 6 weeks in vivo (Greenwald et
al., 1994). Given that the stiffness and strength of the suture material is significantly
greater than human skin, it is unsurprising that the sutures can increase stiffness and
decrease failure strain in skin. However, injury inflicted during suturing creates new failure
points. These data show that suturing can greatly affect skin’s mechanical properties, and
that the extent of the changes to the mechanical properties is highly dependent upon
suture orientation relative to the tensile axis as well as the applied rate of strain, with
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greater strain rates resulting in increased stiffness of the sample. Additionally, these data
provide some interesting insights into the interaction between sutures, applied tension,
and the natural structural proteins found in skin. For example, sutures applied to an injury
in-line with applied tension may effectively off-load stress from viscous components, such
as glycosaminoglycans, as indicated by the low strains observed in samples before
engaging in purely elastic behavior. This also suggests that the high strength and stiffness
of sutures may dominate the local mechanics of a given tissue, but may be counteracted
by damage inflicted during the suturing process as indicated by the similarities in behavior
between the control group and samples stretched 90º to the injury. These data suggest
that we can partially accept our hypothesis that mechanical strength of injured skin with
sutures will increase relative to intact skin, as injured skin stretched in-line with the injury
displayed an increase in fracture strength. However, injured, sutured skin stretched 90ο
to the injury showed a slight (non-significant) decrease in fracture strength, although
elastic moduli were increased for both sutured groups relative to intact skin. It is also
important to note that the maximum strain for both sutured groups was much lower than
intact skin, which may be the limiting factor in addressing potential for further injury during
physical activity.
Conclusion and future work
By assessing comparative data under various strain rates and injury orientation
relative to movement axis, we aim to supply vital information for assessing potential risk
and complications for patients with injuries requiring sutures, particularly athletes
returning to training or physical therapy. By thoroughly understanding the effects of
sutures on skin’s biomechanical properties, the medical community can better advise
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patients with injuries or procedures requiring sutures. Furthermore, the data presented
here can be extrapolated to predict behavior of other soft tissues used in tissue
engineering. In particular, decellularized dermis tissue, such as commercially available
AlloDerm ® are used constantly in plastic surgery procedures (Oh 2011, Shahabiour
2016, Jansen 2013). The decellularized dermis’ success has led to its investigated use in
abdominal repair surgeries, as well as providing the adventitia layer in vascular tissue
engineering (Jansen 2013). In both of these examples, a clear understanding of the failure
mechanism of suturing and tissue strength is crucial for patient outcome, yet these
scenarios are much more challenging to study using conventional technology. This study
can provide a reference for research such as this.

Figure 9. Stress relaxation results. A.) Initial and final stresses recorded for skin
samples without sutures, perpendicular sutures, and sutures in parallel. B.)
Percent decrease in applied stress after five minutes for each of the three groups.
No significant differences were noted between the groups.
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CHAPTER 3. MECHANICAL STIMULATION DRIVES ADIPOSE STEM CELL
DIFFERENTIATION TOWARDS A MENISCUS PHENOTYPE
Publication: Meier EM, Wu B, Siddiqui A, Tepper DG, Longaker MT, Lam MT.
Plast Reconstr Surg Glob Open. 2016 16;4(9):e864.
Elizabeth Meier was responsible for conducting experiments, including biochemical
stimulation and combined biochemical and mechanical stimulation. She compiled data
and assisted with statistical analysis and manuscript preparation.
Introduction
While the high tensile strength of sutures make suturing an attractive modality to
help facilitate repair, they are only practical in injuries capable of self-healing. In tissues
with limited ability to self-repair, such as the meniscus, other approaches must be
considered in order to facilitate wound repair. One such option is the use of stem cells to
create a new cell source to produce the correct proteins to develop a tissue with
comparable mechanical properties as native tissue. In tissues such as the meniscus,
which require mechanical loading to develop properly, it is imperative that mechanical
stimulation be included. Here, we seek to develop a protocol using a combined
mechanical and biochemical stimulus package to promote production of crucial structural
proteins.
One in six knee surgeries are due to meniscus related issues, and many meniscal
injuries are left untreated due to the lack of effective repair methods, causing long-term
damage and accelerated osteoarthritis (Brophy et al. 2012, Arendt et al. 2014, Hasan et
al. 2014, Rothrauff et al. 2016). Successful attempts to repair the meniscus with materials,
cells, or engineered tissues have been limited due to the difficulty of mimicking this
structurally and mechanically complex, heterogeneous tissue (Higashioka et al. 2014,
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Rongen et al. 2014, Scotti et al. 2013, Yuan et al. 2014). Tissue donation from cadaver
sources are often ill-fitting with minimal improvement in mechanical function long-term
(Schuttler et al. 2014). Most meniscus engineering efforts are based on cell-populated
scaffolds but this approach has shown limited success (Schuttler et al. 2014, Bouyarmane
et al. 2014, Longo et al. 2013). Finding a viable cell source for meniscus tissue
engineering remains an issue. Stem cells are a promising option due to proven viability
in clinical trials (Pak et al. 2014).
Bone marrow mesenchymal stem cells (MSCs) have been a common cell type for
study in osteochondral applications, but are not practical for clinical use (Hatsushika et
al. 2014, Nerurkar et al. 2011, Okuno et al. 2014, Vangsness et al. 2014). Adipose-derived
stromal cells (ASCs) are abundant and easily obtainable, capable of being isolated from
fat tissue aspirated from the same patient. Our laboratory has previously shown
successful differentiation of ASCs down the chondrogenic pathway (Xu et al. 2007). ASCs
exhibit fibrogenic qualities, thus, we investigated the potential of ASCs to differentiate into
a mixed fibrogenic and chondrogenic phenotype. Furthermore, undifferentiated ASCs
have already been used in clinical trials, with some success (Pak et al. 2014)
Due to the knee’s dependence on mechanical loading in function and
development, mechanical strain may stimulate stem cells to differentiate into
mechanoresponsive cells (Arendt et al. 2014) Mechanical effects on bone marrow MSCs
has been studied extensively with inconclusive results (Byrne et al. 2008, Case et al.
2013, Kisiday et al. 2009). Here, we investigate the effects of mechanical stimulation on
the differentiation of human adipose-derived stromal cells (hASCs) towards a meniscus
phenotype. Biochemical factors were examined individually, then combined with uniaxial,
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cyclic mechanical strain. Our results show that biochemical factors and mechanical strain
are capable of promoting fibrochrondrogenesis.
Materials and Methods
Stromal cell isolation and media
Human adipose-derived stromal cells (hASCs) were isolated from discarded fat
obtained from elective abdominoplasty and liposuction procedures. Specimens were
obtained with informed consent from patients in accordance with Stanford University,
Wayne State University, and the Henry Ford Health System human IRB guidelines. All
lipoaspiration and abdominoplasty procedures were performed by a board-certified
plastic surgeon. Patient age ranged from 18 to 65 years old, and adipose tissue for this
study were acquired from the flank or abdomen region. Cells from these regions were
selected based on their robust proliferation capability and morphological consistency.
Participating patients had no prior knowledge or evidence of ongoing systemic disease at
the time of operation. All specimens were immediately placed on ice and processed as
follows.
Lipoaspirates were washed twice in Betadine, followed by three rinses in
phosphate buffered saline (PBS). Whole fat was digested in 0.1% type II collagenase
diluted in Hank’s Buffered Salt Solution for 3 hours in a shaking water bath, assisted with
additional mechanical digestion via vigorous hand shaking every 30 min. The digest was
then neutralized by the addition of media with fetal bovine serum and centrifuged at 1000
rpm for 5 min. Supernatant with undigested fat was discarded and the remaining pellet
with stromal cells were resuspended in growth media (GM) and plated at 15 ml of original
tissue volume per 100 mm tissue culture dish.
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The media formulations used are outlined in Table 3. Media components consisted
of Dulbecco’s modified Eagle’s medium with GlutaMax (DMEM, 10569, Gibco, Life
Technologies, Carlsbad, CA), fetal bovine serum (FBS, 26140079, Gibco), penicillin
streptomycin (PS, 15140163, Gibco), ITS+ universal culture supplemental premix (ITS+,
354352, BD Biosciences, Bedford, MA), L-Ascorbic acid 2-phosphate sesquimagnesium
salt hydrate (ASP, A8960, Sigma, St. Louis, MO), dexamethasone (Dex, D4902, Sigma),
and recombinant human transforming growth factor- β3 (TGF-β, 243-B3, R&D systems,
Minneapolis, MN).

FM
1% P/S
10% FBS
-

CM
1% P/S
0% FBS
ITS+ (1:1000)
ASP (37.5 μg/mL)
Dex (100nM)
TGF-β (10 ng/mL)

FM1
1% P/S
1% FBS
ITS+ (1:1000)
ASP (37.5 μg/mL)
Dex (100nM)
TGF-β (10 ng/mL)

FM2
1% P/S
10% FBS
ITS+ (1:1000)
ASP (37.5 μg/mL)
Dex (100nM)
TGF-β (10 ng/mL)

Table 3. Summary of media components and concentrations.

Biochemical differentiation
Culture media for encouraging ASC differentiation into fibrocartilage-like cells was
determined from base fibrogenic and chondrogenic media formulations (Table 3). ASCs
were media differentiated for the customary 21 day culture typically used in chondrogenic
Table 2
differentiation
studies (Mandal et al. 2011). Cells of passage 1-4 were used for these

experiments and pooled. Fibrogenic media (FM) traditionally contains basal media and
fetal bovine serum to promote differentiation into fibroblasts. Chondrogenic media (CM)
is significantly more complex, with the addition of several chondrogenic growth factorsinsulin (ITS+), ascorbic acid (ASP), dexamethasone (Dex), and TGF-β. Two different
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variations of combined fibrogenic and chondrogenic media were tested, composed of all
components of both medias with either 1% (FCM1) or 10% (FCM2) FBS. Serial media
differentiation was also assessed, by subjecting the cells to fibrogenic media followed by
chondrogenic media (FM-CM) switched halfway through the differentiation period (i.e. at
10 days), and vice versa (chondrogenic to fibrogenic media, CM-FM). Complete media
formulations and concentrations of supplements are listed in Table 3. Control media
consisted of minimal essential ingredients for cell survival, i.e. basal media and 1% FBS,
and was termed maintenance media (MM). All media contained 1% penicillin
streptomycin to prevent contamination. Media was changed in all groups every 3 days.
Mechanical strain device
A custom system was built for applying mechanical stimulation to the stromal cells
in the form of uniaxial, cyclic tension (Figure 10). Desired system build features included
an overall small device footprint, the ability to be completely housed in a traditional
incubator, and multiple sample chambers. The system was built to house four separate
culture chambers to enable simultaneous stimulation of multiple samples of cells of
varying parameters. The culture chamber consists of a disposable, commercially
available rectangular culture plate (Thermo Scientific Nunc Dishes, 267061, Waltham,
MA), which ensures sterility with each experiment at low cost. Silicone elastomer
substrates (polydimethylsiloxane or PDMS) were added into the culture chambers as a
stretchable cell culture surface as a means for applying mechanical strain. Inserts were
designed and machined out of acrylic to attach the silicone substrates to an actuating
stage. An actuating stage connects the culture substrates to the actuator, which applies
uniaxial, cyclic tensile strain to the cells. A bottom plate for holding the culture and
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actuator setup together was fabricated out of Plexiglas, and allowed the entire system to
fit easily onto a single incubator shelf as a single unit.
Cell loading and mechanical strain regimes
The human adipose-derived stromal cells were subjected to several different strain
regimes to determine the ideal stimulation protocol for encouraging fibrochondrogenic
differentiation. To enable cell attachment to the non-cell adherent silicone elastomer
stretch surface, the substrate was functionalized with an attachment protein prior to
mechanical stimulation. Laminin (natural mouse laminin, 23017, Invitrogen, Life
Technologies, Carlsbad, CA) reconstituted in phosphate-buffered saline (PBS, 10010,
Gibco) was deposited onto the substrate at a concentration of 2 µg/cm 2, enabling cell
adherence to the surface. Pooled ASCs between passages 1-4 were then plated onto the
polymer substrate. Following overnight attachment, the cells were loaded into the ethanolsterilized stretch device in preparation for mechanical strain application.
Mechanical stimulation parameters were varied one at a time to determine their
individual effects. Parameters varied were time of stretching, applied strain and frequency
of strain. First, cells were mechanically stretched for hourly durations of 1, 2, 3, 4, 5, and
6 hours, while parameters kept constant were strain at 10% and frequency at 1 Hz. At
each hour time point, cells were harvested for gene expression analysis. Based on results
from the biochemical differentiation (described in the Results section), ASCs were
stretched in fibrogenic and chondrogenic medias, separately. The second parameter
varied was strain. Strains of 5%, 10%, 15%, 20%, and 25% were applied to the ASCs for
3 h and 6 h, while frequency was kept constant at 1 Hz. Strain rates were chosen based
on the calculations below. Time points are based on results from the time varying
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experiments. Lastly, frequency was varied from 0.5 Hz, 1.0 Hz to 1.5 Hz for 3 h and 6 h
under 10% strain. Unstretched ASCs served as controls for all experiments.
Gene expression
To determine fibrogenic and chondrogenic differentiation of the ASCs under the
various biochemical and mechanical stimulation parameters, quantitative reverse
transcription polymerase chain reaction (qRT-PCR) was performed. qRT-PCR was
carried out on each sample at the conclusion of each experiment: 21 d for media
differentiation, at the end of each time interval for mechanical strain (i.e. after each hour
time point), and after 3 h and 6 h after the various strain rates and frequencies were
applied. Briefly, total ribonucleic acid (RNA) was harvested from the cells using an
RNAeasy Mini Kit (Qiagen, Valencia, CA), the samples treated with DNAse I (Ambion,
Austin, TX), and the RNA amount quantified with a Qubit 2.0 fluorometer (Q32866, Life
Technologies). To convert total RNA to cDNA, reverse transcription (RT) was performed
by prepping samples using a Taqman Reverse Transcription Kit (Applied Biosystems,
Foster City, CA) and subsequently running the samples on a reverse transcription system
(GeneAmp PCR System 9700, Applied Biosystems). qRT-PCR was performed on an
Applied Biosystems Prism 7900HT Sequence Detection System. All reactions were
conducted in triplicate to verify technical robustness. All results were normalized to
GAPDH. Fibrogenic genes probed were collagen I (Col I) and versican (VCAN).
Chondrogenic genes probed were collagen II (Col II), Sox 9 and aggrecan (ACAN).
Collagen X (Col X) was also probed to mark cell hypertrophy, indicating the beginning
stages of endochondral ossification (Shen 2005).
Histological analysis
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Hematoxylin & eosin (H&E) and Masson’s trichrome stains were performed on
cells following stretching for the strain rate and frequency varying studies. Immediately
following stretching, PDMS substrates with cells attached were removed from the stretch
device and fixed with 10% formalin. Following formalin fixation, samples to be stained
with Masson's trichrome were re-fixed in Bouin's solution for one hour at 56°C. Each
sample was then placed onto a glass slide. Slides were stained using hemotoxylin and
eosin and Masson's trichrome protocols, with the omission of xylene from both protocols.
During preliminary studies, it was determined that removal of xylene from the staining
protocols produced higher quality images and so was not included. Exclusion of xylene
did not adversely affect the stains. Samples were allowed to dry fully prior to imaging.
Statistics
All averages were calculated as mean values ± standard error. Statistical
significance of the media treatments alone was determined with one factor ANOVA tests
with (p < 0.05). All other experiments used a two-factor ANOVA to determine statistical
significance. Tukey post hoc analysis was performed to ascertain significance between
groups, with p-values set at < 0.05. Each stimulation trial was conducted a minimum of
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three times (to ensure n=3 for each data
point) and utilized ASCs from eleven
different donors. Donor cells were pooled
so that ΔΔCt calculations were comparing
treated ASCs and control ASCs from the
same donor.
Results
Media Formulation
To determine the appropriate conditions
for

promoting

the

fibrocartilage

phenotype, the human adipose stromal
cells were cultured in seven different
media

formulations

consisting

of

variations of fibrogenic and chondrogenic
biochemical factors (media descriptions
Figure 11. Cell morphology under the

are

different media types. Black boxes indicate

formulations listed in Table 3). Cell

the cells. In the FM media, cells were

morphology was observed throughout the

elongated similar to normal fibroblast

21 day culture period. Fibroblasts are

morphology. In the FM-CM media, cells were

characterized by elongated, narrow cells

more rounded like chondrocytes, whereas in
the CM-FM media cells were more elongated
like fibroblasts. Scale bars = 100 µm.

listed

in the Methods

section;

whereas chondrocytes are more rounded
in shape. In the different biochemical
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combinations, the stromal cells exhibited morphologies consistent with fibroblasts,
chondrocytes and a combination thereof.
Maintenance media (MM) was formulated to contain the minimum essential
nutrients for cell survival, i.e. basal media with 1% FBS. This media served as the control,
however 1% FBS was not sufficient for cell survival for the entire 21 day culture period,
shown by cell degeneration and death (Figure 11). ASCs in fibrogenic media (FM)
consisting of basal media plus 10% FBS displayed morphology similar to fibroblasts.
Similarly, cells in chondrogenic media (CM) were rounded, resembling chondrocytes. In
the mixed fibrogenic and chondrogenic media (FCM1 and FCM2), cells were initially
rounded in appearance but gradually acquired a more elongated morphology similar to
fibroblasts, with few rounded cells evident in the culture. In FCM2 where the FBS content
was higher than in FCM1, cells were more fibroblast-like with very few rounded cells,
suggesting that cells mostly differentiated towards the fibrogenic phenotype under this
media due to the higher FBS amount. In the media switched from fibrogenic to
chondrogenic media (FM-CM), by 21 days cells were more rounded with some elongated,
fibroblastic-like cells intertwined. When media was switched from chondrogenic to
fibrogenic media (CM-FM), cells took on a more fibrogenic morphology by the end of the
culture period. In both cases of changing media halfway through the culture period, the
ASCs primarily acquired morphology similar to the latter media, indicating that the
dominating differentiation factor was the last media formulation to which the cells were
exposed. Specifically, CM-FM media produced more fibroblast-like cells and conversely
FM-CM media resulted in more chondrocyte-like cells. Although morphology is a useful
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marker, a more quantitative measure is necessary for determining cell phenotype, hence
gene expression of the cells in the different medias was also investigated.
Biochemical formulations induce both fibrogenic and chondrogenic phenotypes
Expression of key fibrogenic and chondrogenic genes were probed to determine
the direction of ASC differentiation towards the fibrocartilage phenotype under the
different medias (Figure 12). Gene expression is presented relative to control,
undifferentiated ASCs. All medias resulted in expression to some degree of fibrogenic
and chondrogenic genes, even in pure fibrogenic or chondrogenic media. In fibrogenic
media (FM), the key fibrogenic gene collagen I increased in expression the most, followed
by a slight increase (100x) in the chondrogenic marker aggrecan. Chondrogenic media
(CM) resulted in a significant increase in the key chondrogenic gene collagen II
expression, and included increase in expression of chondrogenic Sox9 and fibrogenic
versican. Fibro-chondrogenic media mix 1 (FCM1, containing 1% FBS) and the
fibrogenic-to-chondrogenic media (FM-CM) only increased expression of collagen I, and
also showed increased levels of collagen X indicating cell hypertrophy. Fibrochondrogenic media mix 2 (FCM2, containing 10% FBS) only increased collagen X
expression. Chondrogenic-to-fibrogenic media (CM-FM) increased expression of
collagen I, Sox9, aggrecan, and collagen X. Overall, the significant difference in the
presence of the essential collagen II protein with combined increased expression of other
main chondrogenic and fibrogenic genes indicates that the chondrogenic media

61

formulation best promotes the
mixed

fibrochondrogenic

phenotype.

Figure 12. ASCs exhibit increased chondrogen

Hence,

chondrogenic media was used
in the mechanical stimulation
studies.
Mechanical strain device
For applying mechanical
strain

with

parameters,

the
a

desired

device

was

custom built as described in the

ic and fibrogenic gene expression after culture in
the varying media combinations. Gene expression
represented relative to the control maintenance media
(MM). Gene upregulation of the major chondrocytic

Methods section. The device is
marker collagen II was significant in the chondrogenic

able to apply up to 25% strain and up to 1.5 Hz as required by our experiments. The
media (CM). Error bars represent standard error. *

device had no issues operating for the 6 hour time span of the experiments and could be
denotes statistical significance (p<0.05).

run for longer periods of time. The polymeric substrate was fabricated at a 1:15 polymer
base to curing agent ratio, rather than the traditional 1:10 ratio to ensure that the substrate
had enough strength to be able to withstand the tensile forces applied to it while still
remaining compliant. PDMS is an inherently hydrophobic material and thus does not
permit cell attachment. Thus, the substrates were pre-functionalized with the attachment
protein laminin to enable cell adhesion, allowing the cells to remain attached to the
substrate under the applied cyclic strain. For RNA extraction for gene expression
evaluation, cells were easily detached with a cell scraper. Cells could potentially be
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detached from the substrates and collected using trypsin. This would allow for their use
in tissue engineering a knee meniscus.
Mechanical Loading Results
The components that comprise the knee joint are highly dependent on mechanical
cues for proper development. It is believed that these mechanical cues participate in
differentiation of the local stem cells into the fibrocartilage cells of the knee, though the
precise mechanism remains to be elucidated. Thus, mechanical strain was investigated
as a potential stimulant of differentiation of adipose-derived stromal cells (ASCs), a
mesenchymal derived cell, down the fibrocartilaginous pathway. Mechanical stretch was
applied via uniaxial cyclic strain using the custom-built cell stretching device. FM was
used in all mechanical stimulation studies as the control media as it is the conventional
media ASCs are cultured in. CM was used because ASCs expressed the highest levels
of fibrochondrogenic genes in that media (Figure 12), and the greatest differentiation
towards fibrocartilage was desired.
Stretch duration effects
Cells were subjected to mechanical stimulation for hourly increments ranging
between 1 and 6 hours, while keeping constant strain at 10% and frequency at 1 Hz. The
cells were stretched in fibrogenic and chondrogenic media separately. Expression of
relevant fibrogenic and chondrogenic genes by cells subjected to stretch for varying time
durations in each fibrogenic and chondrogenic media is shown in Figure 13. In fibrogenic
media, collagen II expression was increased at early time points and versican increased
at 2, 3, 5, and 6 hours. Collagen X was increased at 3 and 4 hours, showing cell
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hypertrophy. In contrast, in chondrogenic media collagen I and Sox9 expression were
distinctly increased across all time points. At 3 h of stretch, most fibrogenic and
chondrogenic genes were noticeably increased, suggesting that 3 h of stretch in CM
improved fibrochondrogenic differentiation the most.
Strain magnitude effects
ASC were subjected to mechanical strains of 5%, 10%, 15%, 20%, and 25% for 3
h

Figure 13. Mechanical stimulation for 1-6 hours promotes varying
expression of both chondrogenic and fibrogenic genes. Gene expression
represented as relative values compared to control ASCs. Strain was kept
constant at 10% and frequency at 1.0 Hz. Mechanical stimulation in chondrogenic
media mainly promoted increased expression of fibrogenic gene collagen I and
chondrogenic gene Sox 9. Statistical significance (p<0.05) was not observed for
these data.
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Figure 14. Phenotype expression varied with varying strain rates during mechanical
stimulation. Gene expression relative to ASC only controls under 5% -25% strain. Callouts
show 5% strain (A), 10% strain (B), 15% strain (C), 20% strain (D), and 25% (E). Frequency
was kept constant at 1.0 Hz. The data clearly shows a peak of genetic expression at 3 h of
stretch under 10% strain. Error bars represent standard error. * denotes statistical

and
6 h; in FM(p<0.05).
and CM; and at a frequency of 1 Hz. Results are shown in Figure 14. Gene
significance
expression was clearly increased in comparison to the time varying studies, showing that
magnitude of strain had a greater effect on cell differentiation than time duration. At 5%
strain, fibrocartilage genes were more highly expressed after 6 h of stretch compared to
3 h. At 10% strain, 3 h of stretch resulted in higher fibrocartilage gene expression. At 15%
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strain, most genes increased in expression at nearly the same amounts. At 20% strain,
gene expression was slightly higher at 3 h compared to 6 h, with a noticeable increase in
cell hypertrophy at 6 h of stretch. At 25% strain, gene expressed was lower than at other
strain rates shown by a maximum relative expression of 10 7 as opposed to 1010. This
result indicates that the cells were exposed to too high of a strain rate, hindering their
differentiation potential. In the combined graph (Figure 14F), the greatest overall increase
in fibrocartilage gene expression was at 10% strain for 3 h, supporting the use of the
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Figure 15. Strain rates do not affect protein level collagen expression. Protein level
expression of collagen as seen in H&E (pink) and Masson’s Trichrome (blue) stains.
Control tissue with collagen present (i.e. skin) served as the positive control and is
displayed for comparison. Images taken at 40x reveal undetectable protein levels. This data
provides further evidence of the difficulty to achieve full translation of collagen genetic
expression into protein expression when differentiating from stem cells. H&E and Trichrome
stains display mostly cytoplasm and that cells survived at most strains rates, except cell
death can be observed after 6 h of mechanical stimulation at 20% and 25% strains.

parameters of 10% strain and 3 h to promote the meniscal phenotype. Data at 15% strain
for 3 h and 25% strain for 6 h was statistically significant.
Histological analysis using H&E and Masson’s trichrome stains were used to
identify the presence of collagen at the protein level in the cells after stretching (Figure
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15). In H&E, collagen is demarcated by dark pink and the cytoplasm by lighter pink. In the
trichrome stain, collagen is indicated by the color blue. For both time durations across all
strain rates, collagen could not be detected at the protein level. Only light pink indicating
cytoplasm was seen in the H&E stains, and no blue appeared in the trichrome stains. At
6 h of stretch and 20% and 25% strain, cell necrosis and death can be seen in the stain,
supporting the data showing a decrease in gene expression under these parameters,
likely due to overstretching. Positive control stains of skin samples are shown in Figure
15 to show that the lack of collagen staining in the tissue samples was not due to technical
issues.
Frequency effects
Cells were mechanically stimulated at varying strain frequencies of 0.5 Hz, 1.0 Hz
and 1.5 Hz at 10% strain for 3 h and 6 h in chondrogenic media (Figure 16). Relative to
control, undifferentiated ASCs, all fibrochondrogenic genes increased in expression when
strained at the applied frequency range. A strain frequency of 1.0 Hz promoted the highest
increase in gene expression, resulting in a statistically significant increase.
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Histological analysis of the cells stretched at varying frequencies show
undetectable levels of collagen protein expression (Figure 17). Light pink stains in the
H&E samples indicate cytoplasm, with very little dark pink areas indicating possible
collagen protein content. Similarly, in the trichrome stains, blue stain indicating collagen
could not be seen. The cells appeared healthy in all frequency groups. In comparison,
cell death could be seen at higher strain rates (Fig. X). This difference suggests that the
cells were able to adapt to the range of frequencies used, whereas strains over 20%
overstretched the cells and caused cell death.

Figure 16. Mechanical stimulation frequency affects phenotype. Stimulation frequencies
of 0.5, 1.0 and 1.5 Hz were applied to the ASCs for 3 h and 6 h. Strain was kept constant at
10%. Gene expression was significantly increased under 1.0 Hz stimulation for both time
points, suggesting that 1.0 Hz is the ideal strain frequency to subject stem cells to for inducing
fibrochondrogenesis. Error bars represent standard error. * denotes statistical significance.
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Overall, the ideal parameters to promote fibrochondrogenic differentiation of
adipose-derived stem cells is 3 hours of stretch at 10% strain and a frequency of 1.0 Hz
in chondrogenic media, as shown by the greatest increase in expression levels of
fibrogenic and chondrogenic genes.
Discussion
Multipotent stromal cells from adipose tissue were chosen due to their abundance,
non-controversial nature, and potential for ease of harvest and transplantation to the
same patient. Human ASCs can be easily obtained through minimally invasive liposuction
procedures, and even a small amount of adipose tissue can yield millions of stromal cells.
For these experiments, unwanted adipose tissue was donated from liposuction
procedures in the clinic. More importantly, phenotypically, ASCs are similar to fibroblasts
and have been reported to differentiate into chondrocytes (Xu et al. 2007). This
combination of phenotypic characteristics make the ASC an attractive candidate for
fibrocartilage differentiation.
Fibrogenic proteins collagen I and versican were used as fibrocartilage markers as
they are critical to the function of fibrogenic tissues. Collagen I (Col I) plays a key role in
a tissues’ ability to withstand tensile forces and is found in tendons, ligaments, and other
connective tissues that experience large tensile loads. Collagen I’s role in the meniscus
is thus to allow the tissue to withstand tensile loads exerted onto it. Versican (VCAN) is a
proteoglycan that plays a large role in adhesion of cells to the extracellular matrix, and is
present in large amounts in fibrocartilage (Naal et al. 2008).
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Chondrogenic proteins collagen II, Sox9, aggrecan, and collagen X were used to
suggest chondrogenic phenotype because of their significant presence in the meniscus
and their key functional roles. Collagen II (Col I) is an especially important component in
the meniscus as it allows for the tissue to withstand tensile forces. Sox9 is a key
chondrogenic

differentiation

factor.

Aggrecan

(ACAN)

an

extracellular

matrix

Figure 17. Stimulation frequency does not affect protein level collagen
expression. Protein level expression of collagen as identified by H&E (pink) and
Masson’s Trichrome (blue) stains. Control tissue with collagen present (i.e. skin)
served as the positive control and is displayed for comparison. Collagen protein was
not observable at 40x magnification, indicating the insignificant amounts of collagen
protein present in the differentiated stem cells, which is in clear contrast to the
noticeable increase in collagen gene expression found in the PCR analysis.

Images for both H&E and Trichrome stains display mostly cytoplasm, and that cells survived

well at all frequencies tested.
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proteoglycan that also aids cartilage in bearing compressive loads. Lastly, collagen X
demarcates endochondral ossification.
Protein expression and presence after differentiation treatments is often included
to strengthen claims of full or partial stem cell differentiation. Although protein expression
was attempted, protein quantities were too low to be detected in mechanically-stimulated
trials. This is expected, as treatment times ranged from 1-6 hours, which is considered
too brief of a period given the amount of cells used for any significant protein production
in adult chondrocytes, let alone pre-differentiated or immature cells (Pelaez et al. 2009).
Continuation of culture after treatment was considered, but ultimately rejected as gene
expression changes were dependent upon mechanical stimulation. Therefore, the cells
would risk de-differentiation if allowed to continue to culture after stimulation and effects
of mechanical stimulation would be lost.
The combination of the aforementioned fibrogenic and chondrogenic proteins give
the knee meniscus its unique phenotype, allowing it to meet its functional demands. The
meniscus experiences tensile and compressive loads- collagen I, collagen II and
aggrecan allow the meniscus to bear these loads. The concentration of these proteins
vary within different regions of the meniscus in relation to concentrations of tensile,
compressive, hoop, and shear stresses, further contributing to the heterogeneity and
uniqueness of the fibrocartilage phenotype.
Adipose-derived stromal cells were treated in the various media formulations over
a period of 3 weeks to allow for progress towards chondrogenic differentiation. By
comparison, pre-fibrogenic differentiation occurs at a much faster rate, taking from a few
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days to a week. Progression towards a differentiated state, or “pre-differentiation” was
evidenced by a changed morphology and enhanced relative gene expression by the cells.
For pre-chondrogenic differentiation, the ASCs would appear more rounded in shape,
indicative of chondrocytes. Under fibrogenic media, ASCs assumed a more elongated
shape with many new cellular extensions, resembling natural fibroblast morphology.
For the fibrogenic-to-chondrogenic (FM-CM) and chondrogenic-to-fibrogenic (CMFM) medias, the objective was to promote the mixed fibrochondrogenic phenotype. The
media was switched between the two media types halfway through the culture period, i.e.
10-11 days through the total 21 day culture, to maximize time exposure of the cells to
each media. Interestingly, the ASCs appeared to acquire characteristics of the latter
media, suggesting that maintaining stromal cell adaptations is dependent upon
continuous stimulation. Switching medias did not result in a mixed phenotype.
Expression of collagen I was seen in nearly all media groups that contained
fibrogenic media components. This may indicate that 1) adipose-derived stromal cells
have a tendency for fibrogenic differentiation given the correct fibrogenic media
conditions, 2) fibrogenesis may be the dominate differentiation direction given traditional
media components (since FM is the conventional media for culturing ASCs), and 3) the
presence of fetal bovine serum may be an adequate stimulus to encourage fibrogenesislike differentiation. No increase in collagen I expression was seen in the fibrochondrogenic media 2 (FCM2) compared to increased collagen I expression in the fibrochondrogenic media 1 (FCM1), indicating more fibrogenesis even though the serum level
was lower. This was possibly due to the fact that in FCM2, and under the conditions of
10% FBS and 3 weeks of culture, the cells began to overgrow and may have transformed
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into other, unknown phenotypes as commonly seen in cell culture overgrowth. Collagen
II expression, a chondrogenic marker, was understandably highest in the chondrogenic
media group (CM). No relative increase in collagen II expression levels was seen in the
FCM1, FCM2, FM-CM, and CM-FM groups, despite the presence of chondrogenic
factors. This effect is most likely due to the dominance of the fibrogenic components in
the medias.
Considering that chondrogenic media resulted in the highest relative expression of
both multiple fibrogenic and chondrogenic genes, this media was determined as the
optimal media formulation to obtain the mixed phenotype during the tensile strain testing.
Although Collagen I expression was minimal under Chondrogenic Media, cyclic, tensile
strain has been shown to increase Collagen I gene expression and encourage
fibrogenesis (Connelly et al. 2010, Kessler et al 2001). This suggests that using
chondrogenic media, which exhibited the highest collagen II expression while still
expressing the fibrogenic gene versican, has the greatest potential for obtaining a mixed
fibrocartilage phenotype when combined with cyclic tensile strain.
Following comparison of biochemical factors, tensile strain was added as a second
stimuli. Strains of 10% at 1Hz for 1-6 hours were initially applied, based both on our
preliminary calculations in Appendix A as well as support from other studies investigating
mechanical stimulation in connective tissue formation (Connelly et al. 2010, Kessler et al.
2001, Pelaez et al. 2009). In CM, ASCs subjected to mechanical stretch consistently
displayed higher levels of fibrogenic gene collagen I than in CM or FM alone, supporting
our hypothesis that the tensile strain would support expression of collagen I in the
presence of CM.

At 3 hours of stretch in CM, the combination of fibrogenic and
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chondrogenic gene expression was highest. At longer stretch duration, chondrogenic
gene expression decreased, while fibrogenic gene expression remained relatively high.
This is likely due to the dominance of mechanical stretch to produce more fibrogenic cells,
and at longer stretch times fibrogenesis gradually dominated over chondrogenesis
resulting in lower chondrogenic gene expression.
The three mechanical stimulation parameters investigated of stretching time
duration, strain rate and stimulation frequency showed different levels of effect on the
ASCs. The greatest increase in gene expression was seen in the frequency varying data,
followed by the strain rate data. Thus, frequency had the greatest effect on fibrocartilage
phenotype changes. Strain had the next greatest effect, and time duration had the least
relative effect.
There were no issues with removing cells from the stretching substrates for RNA
extraction, but a method will need to be determined in order to remove the cells as a cell
sheet for subsequent whole tissue meniscus tissue engineering. The cells cannot be
simply dissociated from the substrate as differentiated cells will not retain their phenotype
once dissociated and/or will simply apoptosis.
Chondrogenic differentiation is traditionally performed in a 3D culture, and usually
as a pellet culture. This is because chondrocytes require high cell density and close
proximity between cells. Hence, there is a level of difficulty in attempting to induce the
chondrogenic phenotype on a 2D surface, i.e. that of the stretch device substrate. There
is some evidence that chondrocytes and bone marrow mesenchymal stromal cells
(MSCs) are able to differentiate into cartilage under certain 2D conditions (Galle et al.
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2010). While the factors of 2D culture and tensile stretch favor fibrogenesis, they do not
encourage chondrogenesis. Hence, chondrogenesis was mainly induced by the use of
chondrogenic media and by the chondrogenic growth factors within it. In this way, we
were able to still achieve a chondrogenic phenotype on a 2D surface.
Conclusion
We demonstrated for the first time, to our knowledge, the ability to encourage
fibrocartilage-like differentiation from human adipose-derived stromal cells using tensile
strain. Mechanical stretch along with biochemical factors promoted this mixed phenotype.
The challenge of producing the chondrogenic phenotype on a 2D surface, i.e. the stretch
substrate, was overcome by stretching in chondrogenic media. These fibrocartilage-like
cells provide a valuable stepping stone towards obtaining a fully mature, differentiated
fibrocartilage phenotype that could be used in tissue engineering applications down the
road.
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CHAPTER 4. IMPACT OF CARDIAC PATCH AND IBUPROFEN ON INFLAMMATION
FOLLOWING MYOCARDIAL INFARCTION
Publication: Meier EM, Wu B, Xu Z, Lam MT.
Tissue Engineering A- Submitted
Elizabeth Meier assisted with experimental design. She was responsible for
approximately half of all surgeries as well as post-operative care. She conducted PCR,
IF analysis, histology, and blood smear sample preparation. Bin Wu conducted the
remaining surgeries. Zhengfan Xu assisted with histology, immunofluorescence, and
sample preparation. Ashley Apil, Tiara Heard and Bijal Patel assisted with cell counts
and double blinding, respectively.

Introduction
So far we have determined that direct mechanical intervention can assist in wound
healing in certain tissues (ex. skin), but not in other tissues with limited capacity to heal
(ex. meniscus). Like the meniscus, heart tissue has limited capacity to regenerate, due to
extremely low cell replication. However, unlike the meniscus, heart tissue is highly
vascularized, resulting in a high capacity for inflammation and scar tissue formation.
These are the physiological events that occur in major cardiac tissue injuries, including
myocardial infarction. Myocardial infarction (MI), commonly known as heart attack, is a
sometimes deadly injury that can lead to heart failure and death.
One of the major complications of MI is cardiac remodeling and improper scar
tissue formation. One of the more popular research topics to address this remodeling is
to suture a biomaterial patch to the cardiac tissue to increase wall thickness and increase
cardiac function. Natural, decelluarized tissues, such as porcine small intestine
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submucosa (SIS) are frequently used. These materials are attractive for MI treatments
because they have been shown to promote angiogenesis and retain delivered cells and
growth factors (Vanoos et al. 2016 Zhang et al. 2015, Mewhort et al. 2016 ).
However, it is largely unknown how addition of a collagen-based patch affects the
inflammatory process of the tissue. Collagen-based decellularized tissues have been
used in a wide variety of reconstruction surgeries (Jansen et al. 2013, Ibrahim et al. 2013),
with a wide range of inflammatory responses reported. Furthermore, many of these
materials incite a different inflammatory response between locations and applications in
the body, making extrapolation of results between applications ill-advised. For example,
AlloDerm, a collagen-based decellularized dermal layer, has minimal reaction when used
in breast reconstruction, but is quickly encapsulated and infiltrated by macrophages when
used in abdominal reconstruction (Broderick 2012, Ibrahim 2013). It stands to reason that
in the case of a myocardial infarction treatment, the physiological response would differ
from either of the two previous applications. While none of the documented responses to
SIS, AlloDerm, or any other similar decellularized tissue, have been severe enough to
warrant discontinuing use of the material, this variation suggests further study is needed
before any such material is used to treat severe injuries, like myocardial infarction.
To address this gap in knowledge, we propose to use a porcine small intestine
submucosa (SIS) patch on a rat infarct model. The SIS material has been used
successfully in infarct studies (Lam et al. 2013, Wendel et al. 2014, Zhang et al. 2015).
These studies have proven that a porcine SIS patch can improve cardiac mechanical
measures, such as ejection fraction, at least as well as other patch materials (Lam et al.
2013, Wendel et al. 2014, Zhang et al. 2015, Mewhort et al. 2016). Porcine SIS is
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commercially available through Cormatrix, which has supplied the material for clinical
heart valve repair and pericardium replacement, among other uses (Gerdisch et al. 2014).
While it is an approved material with numerous studies conducted on its efficacy and
safety, its effects on the inflammatory response in an injury state, such as myocardial
infarction, are currently unknown. Due to the addition of a foreign material, we expect that
initial inflammation may be increased relative to infarct without any patch treatment. To
attenuate the increased inflammation, we expect that inclusion of an anti-inflammatory
agent, ibuprofen, may counteract this. To effectively evaluate how application of an SIS
patch may influence the inflammatory response post- MI, we plan to observe multiple
aspects of the inflammatory response in a rat MI model, with use of an SIS patch with
and without ibuprofen to determine how inflammation will be affected through day 7 postMI. Seven days was selected as the duration for the experiment as it has been suggested
as a rough timeline of the inflammatory response conclusion in a rat MI model (Turer
2011, Altara 2016 ).
Three subject groups will be used; infarct-only (control), infarct + patch, and infarct
+ patch +ibuprofen. Each group will be evaluated daily through seven days for gene
expression, protein expression, histology, and leukocyte counts. It is our expectation that
this analysis will present a clear view of the impact of a porcine SIS cardiac patch on the
inflammatory response after myocardial infarction.
Methods
Myocardial Infarction Model
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Rats were selected for the infarct model due to their similar healing mechanisms
to humans. Myocardial infarction surgery was be performed in 200-225g female SpragueDawley rats through left coronary artery ligation. Surgical procedures will be conducted
as outlined in the approved IACUC protocol A-03-06-14. Immediately prior to the surgery,
a baseline echocardiogram was performed, after which the animal would be randomly
assigned to a group. Animals were allotted into groups using a random number generator
(RANDBETWEEN function) in Microsoft Excel. A return value of “1” designated the animal
as infarct-only, “2” corresponded to patch only, and “3” received patch and supplemental
ibuprofen. Animals were anesthetized with isoflurane and intubated. The heart was
exposed via thoracotomy and the left descending coronary artery was occluded using a
6-0 suture slipknot with thread. The artery was occluded for 45 minutes, during which
moist sterile gauze was placed over the opening to limit dehydration. After the 45 minutes,
the slipknot was removed to allow for reperfusion and the patch applied (where
applicable). For designated animals, the SIS patch was visually aligned over the infarct
area and sutured into place using two 6-0 sutures. This process can be seen in Figure
18. After the patch is applied, the wound is closed and the animal will receive pain
medication and a bolus of saline to prevent dehydration. Analgesics were provided every
12 hours and MI confirmed via echocardiogram after 24 hours. Animals in the patch+
ibuprofen group will be given children’s ibuprofen daily via syringe feeding. Dosage of
supplemental ibuprofen was 30 mg/kg body weight/ day. Dosing was determined based
on pharmacokinetic analysis of ibuprofen in Sprague-Dawley rats (Fu 1991). Animals not
receiving ibuprofen were syringe fed with a placebo. Animals were sacrificed at days 1,
2, 3, 4 5, 6, or 7, with death confirmed via heart removal.
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Gene Expression
PCR analysis was performed to assess the state of the tissue at each time point.
Key inflammatory markers MMP 1, MMP 2, and MMP 8 were examined. Collagen I will
be investigated for fibrosis and scar formation. TGF-β and TNF-α were reviewed for
information about the presence and type of
inflammation, along with IL-1RA. Neutrophil
presence and activity were indicated with
neutrophil

elastase

and

neutrophil

chemotactic factor (CF) 2. Primers were
identified from Harvard Primer Bank and the
corresponding custom DNA oligos will be
ordered from Life Technologies. Primer

Figure 18. Placement of the SIS patch on
infarct area. After reperfusion, 6 mm patch
will be manually placed over the infarct and

sequences are outlined in Table 4.
held in place with sutures.

Following sacrifice, rat heart tissue will be crushed using a mortar and pestle.
Then, the steps outlined in the RNeasy minikit instruction manual (page 6-7) will be
performed to extract RNA. A Beckman Coulter Microfuge 18 Centrifuge will be used for
this process. Following the RNA extraction process, RNA will be stored in -80C or
immediately used in downstream steps. Before cDNA production can take place, we will
determine the concentration of RNA in each sample using a Qubit 2.0 Fluorometer and
reagents (Invitrogen/Life Technologies). To quantify RNA, 199 uL of Qubit RNA buffer
solution and 1 mL of Qubit RNA fluorescent reagent will be added to a 250 uL tubule.
Eight microliters will be extracted from the 200 uL mixture and 8 uL of the RNA solution
will be added. The quantity of 8 uL was selected due to the potential for low RNA
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quantities in the infarct tissue. The tubule will be vortexed and then placed in the
Fluorometer for quantification. If RNA quantities are undetectable, the process will be
repeated with 20 uL solution removed from the 200 uL mixture and replaced with 20 uL
of RNA solution. Once the quantity of RNA is determined, preparations for cDNA will
begin.
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Complementary DNA will be produced using Taqman Reverse Transcription
Reagents kit (Applied Biosystems Branchburg, NJ). The reagents will be mixed as
indicated in the kit instructions. Once the solution had been prepared, 6.525 uL will be
added to four 0.2 mL flat cap tubules (Fischer Scientific). RNA will be mixed with a
calculated amount of RNase-free water. Calculations are conducted so that equal

Gene

Abbreviation

Description

Sequences
GTTGCTGCTTGCAGTAACCTT
AGGGCCAAGTCCAACTCCTT

Collagen I

Col I

Expressed during fibrosis.

MMP-1

MMP-1

Collagenase I, II, III MMP. Seen
during remodeling and
inflammation.

AAAATTACACGCCAGATTTGCC
GGTGTGACATTACTCCAGAGTTG

MMP-2

MMP-2

Collagenase IV, gelatinase. Seen
during remodeling and
angiogenesis.

TACAGGATCATTGGCTACACACC
GGTCACATCGCTCCAGACT

MMP-8

MMP-8

Neutrophil collagenase.

TGCTCTTACTCCATGTGCAGA
TCCAGGTAGTCCTGAACAGTTT

TGF-β

TGF-β

Involved in inflammation and other
processes. Produced by
macrophages during inflammatory
response.

AACTGCTTCCTGTATGGGGTC
AAGGCGTCGTCAATGGACTC

TNF-α

TNF-α

Tumor necrosis factor, released by
macrophages during inflammatory
response.

CCTCTCTCTAATCAGCCCTCTG
GAGGACCTGGGAGTAGATGAG

Neutrophil Elastase

NE

Serine protease released by
neutrophils and macrophages
during inflammation.

CTCGCGTGTCTTTTCCTCG
GCCGACATGACGAAGTTGG

CD14

CD14

Monocyte, macrophage marker

ACGCCAGAACCTTGTGAGC
GCATGGATCTCCACCTCTACTG

Chemotactic Factor 2

CF2

Neutrophil chemotactic factor 2.
Factor released during
chemotaxis.

CCCACTCCCGGATTTGCTTC
GTCTCGGTTAATGCTTCTGGTAA

IL-RA

IL-RA

Interleukin receptor antagonist 1.
Produced by M2 macrophages.

GCGAGAACAGAAAGCAGGAC
CCTTCGTCAGGCATATTGGT

Table 4. List of inflammatory marker genes and primer sequences.
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amounts of RNA are included in each sample. Once the water is added to the RNA
solution, 3.475 uL of the resulting mixture will be added to each tube, totaling 10 uL. Once
the cDNA reagents are prepped, each reagent should be placed within a 2720
Thermocycler (Applied Biosystems). Once the program has finished its run, cDNA will be
stored at -20C for up to 24 hours, or used immediately in downstream applications.
PCR
PCR was conducted using StepOne Plus Real-Time PCR (Applied Biosystems).
The accompanying StepOne v2.2.2 software was used to set up the experiment. Each
gene and sample were assessed in triplicate and two controls used: negative control with
no cDNA, and cDNA from the MI-only tissue.
The plate design was executed in a MicroAmp Fast Optical 96-well reaction plate
from Applied Biosystems. Each well received 2.0 uL of the cDNA sample and 0.4 uL of
both the forward and reverse primers. Negative controls received 2.0 uL of RNase-free
water in lieu of cDNA. All wells received 7.6 uL of RNase-free water, for a total of 10 uL
of solutions. The plate was then covered with aluminum foil to block light as 10 uL Power
SYBR Green PCR Master Mix (Applied Biosystems) was added to each well. Once the
plate was loaded and cycles completed, gene expression fold-increase was calculated
from CT values provided by the software.
Differential Quick Stain
In order to determine the proportion of inflammatory cells within each time point
and group, a Differential Quik (Diff-Quik) blood smear stain was performed. This stain is
commonly used in immunology and inflammation studies to assess different inflammatory
responses (Van Hout et al. 2015, Geissman, et al. 2010, Godwin et al. 2016). Coronary
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and ventricular blood was extracted from each tissue sample using a syringe immediately
after sacrifice. Blood was dropped onto labeled slides and spread using a spreader slide.
Each slide was fixed and stained using a
three step process using PolyScience’s
Differential-Quik Stain (Warrington, PA).
Once the stains set, groups of one
hundred

cells

were

counted

and

neutrophils and monocytes were tallied.
Neutrophils are signified by dark blue
nucleus and granules with pink cytoplasm.
Monocytes appear with lobulated, violet

Figure 19. Diff-Quik stain of example blood
smear. This smear shows a neutrophil and a
lymphocyte in the 100-cell count of the smear.

nuclei with light blue cytoplasm, an
example is shown in Figure 19. Following staining, each slide was relabeled by another
researcher blinded to the study to prevent bias during data collection and analysis. In
order to ascertain quantitative differences, each smear was viewed at 6 different
locations, selected at random by two double blinded researchers with no relation to the
study. The leukocytes were tallied per approximately 100 cells, with the exact cell count
being included. The tallies at each location were averaged per sample, with three samples
being assessed per each treatment group at each time point, for six points for blood
smears from animals receiving infarct only, infarct + patch, and infarct with patch and
ibuprofen groups at days 1-7 post-infarct. Six sham animal smears were included as an
additional control.
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Histology and Immunofluorescence
Samples for histological examination will be excised and frozen at -80C in OCT for
a minimum of 24 hours. After samples have been thoroughly frozen, samples will be sliced
in 6 um sections using a Cryotome. Section thickness was determined during preliminary
staining to determine optimal thickness for staining visibility. Section slicing will be done
starting with the apex of the heart, near the infarct area, moving upwards along the heart
through the infarct zone. Each slice will be numbered, with every other slice being allotted
to either histology stain or immunofluorescence for a total of thirty slices equidistant
throughout the heart. Ten slices will be allotted for IF, while the rest will be allotted for
picrosirius red, and hematoxylin and eosin. This way, each stain will have an equal
representation of the infarct area while minimizing the number of animals needed. By
analyzing multiple slices throughout the infarct region, we will be able to evaluate the
distribution of key inflammatory cells throughout.
Histology
Histological evaluation provides qualitative evidence of tissue damage and infarct
size. Hemotoxylin and Eosin (H&E) and Picrosirius Red was used to delineate the infarct
area, healthy muscle, deposited collagen and the SIS patch, where applicable. H&E
staining was performed with 6 μm sections from two animals to confirm qualitative
evaluation. The same size slices was used for Picrosirius Red evaluation. Tissue samples
stained with Picrosirius Red were also observed under polarized light to aid in collagen
deposition and maturity analysis.
Immunofluorescence
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Immunofluorescence (IF) staining was conducted to identify CD45AB, and was
used to assess the presence, location, and density of inflammatory cells (leukocytes) in
the infarct area. To separate collagen’s autofluorescence from the CD45AB signal, the
slides were imaged prior to IF staining and assessed for brightness using ImageJ (U.S.
National Institutes of Health, Bethesda, MD). The samples were then assessed using
ImageJ after staining to determine the difference in brightness, and therefore the
presence of leukocytes. The quantitative differences between the before and after images
were used to determine the relative presence of leukocytes between time points and
treatment groups. This was conducted for nine slices within each sample, with the same
corresponding slices evaluated between the groups. For example, if the tenth slice was
analyzed for one sample, it was analyzed for the remaining samples. Each slice was
imaged at a minimum of three locations to account for local variability. All brightness
measurements were included in the analysis.
Tensile Testing
It is well established that healed wounds exhibit different mechanical behavior than
that of native, intact tissues. Of particular note is the presence of scar tissue, which
increases the elastic modulus of the tissue and can alter the anisotropy of the tissue.
However, thick, intact scar tissue is not fully formed during the inflammation process and
therefore little is known about the immediate changes in mechanical properties following
an infarct. To evaluate the mechanical changes in the heart post-MI and how a collagenbased SIS patch may affect these changes, tensile testing was conducted on all day 7
tissue samples. Tensile testing was conducted on a Cell Scale UStretch uniaxial
mechanical tester (CellScale, Ontario, Canada). Samples were stretched at a rate of 2
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mm/min with data collected five times per second. Three tissue sections were procured
from each heart sample with three hearts used for each treatment group plus a sham
group. SIS patches were gently removed with forceps prior to tensile testing for applicable
samples. Elastic modulus, ultimate tensile strength and failure strength were calculated
and compared using one-way ANOVA with Tukey post-hoc tests.
Statistics
All averages will be calculated as mean values ± standard error. Statistical
significance for PCR was determined with two factor ANOVA with an alpha value of 0.05.
Tukey post hoc analysis was performed to ascertain significance within groups, with pvalues set at 0.05. Ad hoc power analysis was included to ensure sample size accuracy,
with a post-data power analysis yielding β= 0.76, which is close to the 0.80 used to
calculate the sample size. The same statistics were used for the leukocyte counts in the
blood smears. Brightness, or leukocyte presence in the tissue, was also assessed using
a two-factor ANOVA with the same parameters. Elastic modulus, ultimate tensile strength
and failure strength from tensile testing were calculated and compared using one-way
ANOVA with Tukey post-hoc tests. Sample sizes for quantitative measurements were
determined completing a power analysis. Initial sample sizes were estimated based on
published data from similar studies that confirmed the sensitivity of Differential Quik
staining (Selvi et al. 2000, Silverman 1995) and cell and gene expression in inflammatory
studies (van Hout 2015, Vuohelainen 2014). Histology, and polarized light microscopy
were evaluated qualitatively. All statistical design and analysis were completed with the
assistance of Wayne State University’s Research Design and Analysis (RDA) consulting
unit.
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Results
Expression of Inflammatory Genes
PCR results were compiled and organized into groups of related inflammation
factors. Matrix metalloprotease (MMP) expression is shown in Figure 20A-D. MMP
expression overall showed minimal difference between the groups, with the exception of
significant down-regulation of MMP-2 at day 7 relative to infarct-only (Figure 20). As seen
in Figures 20E-H, neutrophil activity is overall elevated in the first 5-6 days post-injury
relative to the infarct-only group. However, by day 7, expression of all neutrophil markers
was below that of infarct-only. This, along with the elevated MMP expression during this
time, suggests that neutrophil activity, and potentially population, is elevated at
approximately days 3 – 6 in animals receiving the patch, relative to animals that received
only the infarct. The overall lack of difference in expression between the patch groups
suggests that the ibuprofen, either through mechanism or dosage, does not significantly
affect neutrophil gene expression post-infarct.
Figure 20I-L shows increased expression of key inflammatory markers in the patch
treatment groups at days 2-3 and at days 5-6 relative to the other time points. These
markers are expressed by, but not exclusively by, macrophages and thus only limited
conclusions of macrophage activity can be drawn. That said, these data suggests that
gene expression of these key genes can somewhat effectively “track” macrophage
presence, while providing information about the inflammatory process, as the gene
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Figure 20. PCR results plotted over time relative to infarct only. Dotted lines indicate infarct
only expression. All significant results were relative to infarct only, indicated by * (P < 0.05).
Genes were grouped based on physiological relevance. MMPs 1, 2, and 8 are shown in A-D.
MMPs showed a clear decline in expression over time. Neutrophil genes CD14, neutrophil
elastase and CF 2 are shown in E-H. Neutrophil markers have a net decrease in expression
over time, and expression levels remain consistently lower than infarct only expression
levels at the end of day 7. Macrophage markers are shown in I-L, with TGF-β and collagen I
in M-O. Macrophage expression shows higher expression around day 2-3 and 5-6 relative to
the other time points. Error bars have been removed from combined graphs (A, E, I, M) for
clarity. I + P = patch only; I + P + IB = patch and ibuprofen.

expression neatly follows the timeline of macrophage activity in inflammation outlined in
literature (Altara et al. 2016). This is particularly apparent when reviewing IL-RA
expression, which has clear peaks at expected macrophage infiltration times. Specifically,
the expression peaks during the first few days of inflammation, when the local, proinflammatory macrophages (M1) are most often active, and then peaks again towards the
end of inflammation when the population of circulating, anti-inflammatory macrophages
(M2) is highest.

Figure 20M-O supports the increased macrophage expression, as

collagen I expression is lower in the later stages of inflammation in both treatment groups
relative to the infarct-only group. Interestingly, during the middle days of inflammation,
collagen I expression is increased relative to the infarct-only group. This suggests that
overall collagen I expression is not lower between groups, but rather may be expressed
on an accelerated timeline in groups receiving the patch treatment after infarct. As shown
in Figure 20M, the expression of collagen I is related closely to the expression of TGF-β,
which is expressed by macrophages as well as other cell types in the area. Clearly, these
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data cannot give a complete picture of the differences in the inflammatory process
between the groups, however it can provide valuable evidence when combined with other
data, as described next.
Evaluation of Leukocyte Populations
Analysis of the neutrophil and macrophage cell counts was conducted using a two
factor ANOVA model in SPSS. These results are outlined in Table 5. The change in
neutrophil counts over time was significant for all groups (p = 0.004). Macrophage counts
also varied significantly over the 7 day period for all groups (p = 0.008). Significant
decreases in neutrophil counts were noted for all groups between days 2 and 6 (p = 0.047)
and days 2 and 7 (p = 0.014). Similarly, macrophage counts yielded significant differences
between early and later timepoints throughout the experiments for all groups. Significant
differences were noted between days 1 and 6 (p= 0.002), 2 and 6 (p= 0.022), 3 and 6 (p=
0.001), 4 and 5 (p= 0.049), and 4 and 6 (p= 0.008). These differences are likely due to
the low macrophage counts at day 4 and the higher counts at day 6. These results are
similar to other inflammation studies that show the greatest macrophage population
towards the end of the inflammatory period, generally around day 7 (Altara et al. 2016,
Stuart et al. 2016, Giroux et al. 2000, Fu et al. 1991). Therefore, these results do not
suggest significant ill effects from the treatments. Differences in neutrophil counts
between groups were significant at days 4 (p = 0.05) and 6 (p = 0.01), due to the higher
neutrophil presence in the patch + ibuprofen group. Differences in macrophage counts
were significant between groups at day 2 (p = 0.004), with the patch + ibuprofen group
having lower population than the other two groups. As macrophage populations remained
low in the group receiving ibuprofen, it may indicate that the ibuprofen slowed the
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inflammation process slightly, delaying the arrival of circulating macrophages and limiting
the influx of cells. Also significant were the counts at day 4 (p = 0.03), this time due to the
lower macrophage population in the infarct-only group. This may be due to a heightened
response to the patch treatment, resulting in a greater population of macrophages
traveling to the injury area. An example of the smears can be seen in Figure 19.
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Table 5. Means and standard deviations for neutrophil and
macrophage counts. No significant differences were noted between
groups. Significant (p < 0.05) differences between days within
treatment groups are designated by matching symbols. IB = Ibuprofen.
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Leukocyte Location and Density
While analysis the of the Quik Diff stains yielded useful information about the cell
populations, the cell counts do not provide information about the leukocytes’ locations
within the infarcted area. Tissue samples from day 7 stained with CD45AB antibodies
were viewed under fluorescent light and cell location and density observed (Figure 21).
The CD45AB antibody exclusively identifies monocytes and neutrophils in rats, although
it does not allow for identification between the two cell types (van den Berg 2001). It was
immediately apparent that leukocytes respond to the patch, as a high density of
leukocytes are located on the periphery of the patch in both the infarct + patch and infarct
+ patch + ibuprofen groups (Figure 21). However, there was no clear area of high
leukocyte accumulation in the infarct only tissue. It is highly likely that the majority of the
cells seen in these images are macrophages, due to the low neutrophil gene expression
(Fig. 20) and low neutrophil counts (Table 5) at day 7. To evaluate the differences in
leukocyte population within the tissue, images were analyzed before and after fluorescent
labeling of CD45AB antibody, with the resulting average difference in Table 6. The
average difference is the average readout of brightness due to the antibody labeling and
was performed to reduce readout error due to collagen and other background effects.
This provides a more direct comparison between groups, as images had varying levels
of background signal, which can influence the difference in the brightness readouts before
and after fluorescent labeling. The data shown in Table 6 overall shows a strong
correlation with the cell counts (Table 5). Overall, both patch groups generally had higher
brightness values, or higher leukocyte populations, within the tissue, than the control
tissue from the corresponding day, indicating that the addition of the patch resulted in
greater migration of leukocytes. The values at Day 1 seemed to display the most variation
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between the cell counts and the ImageJ analysis, likely due to the sensitivity of the
inflammation process in the first 24 hours of the inflammatory process. The surgical
process allowed for variations of up to 6 hours from infarct until sacrifice for 1 day animals,
which may account for the variability in the leukocyte counts. Leukocytes, particularly
neutrophils, are activated within the first few hours of injury, and therefore a few hours
could make a large impact on population counts (Feng et al. 2015). However, after day
1, results were consistent and leukocyte population in the tissue appeared to follow the
same population flux as the cell counts, with an overall peak in cell population at Day 5.
These data combined suggest that the patch treatments do not necessarily prolong the
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inflammatory response relative to infarct-only, but may result in an elevated inflammatory
response that is resolved quickly.

Table 6. Summary of brightness difference between groups. Brightness indicates average
leukocyte presence. Overall, increases in leukocytes were seen throughout the 7 days with small
peaks around day 3-4 and 6-7.

Figure 21. Immunofluorescent images showing DAPI and CD45AB (leukocyte) stains. A
higher density of cells can be seen around the patches in the patch treatment images. Cells
are more evenly dispersed in the infarct only samples. I = infarct; P = patch, C = collagen.
Scale bar = 200 μm.
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Collagen Deposition in the Infarct Zone
Tissue samples from day 7 show the beginning of deposited collagen in all groups.
However, the samples receiving only the SIS patch and no ibuprofen after infarct had a
much more defined collagen layer than either of the other two groups. Of note is the
collagen surrounding the patch itself, which may be indicative of early encapsulation. SIS
implants been known to result in encapsulation in other uses (Jansen et al. 2013, Ibrahim
et al. 2013). The collagen
deposition on the cardiac
surface,

however,

appears to be similar in
thickness and

volume

between the two patch
groups. Interestingly, the
collagen in the infarct
only group appears to be
thinner,

than

in

the

treatment groups (Fig.
22).

Figure 22. H&E and Picrosirius Red stained tissue samples.
“I” indicates the infarct area.. I = infarct; P = patch; C =
collagen. Scale bar = 1000 μm.

Collagen Maturity
Analysis
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Picrosirius red stained slides were viewed using a polarized filter in a Zeiss
Axiovert 200. Under polarized light, mature collagen fibers appear red or orange while
thinner, less mature fibers appear yellow or green. Generally, infarct models show little
immature collagen fibers within the first week, but up to 95% mature collagen after 5
weeks (Wan et al. 2013, Rich et al. 2005). Figure 23 shows samples from infarct only,
infarct + patch, and infarct + patch + ibuprofen. All three groups showed some signs of
new collagen deposition: thin, immature green fibers in the infarct area. The most
interesting difference between the three groups was not in the infarct zone itself, but in
the collagen surrounding the patch in the treatment groups. As noted in the histological
analysis, the infarct + patch group had a much larger layer of collagen surrounding the
patch than the infarct + patch + ibuprofen group. The collagen also appeared to be more
mature than the collagen in the infarct zone, as indicated by the orange color. Also of note
was that the infarct + patch + ibuprofen group appeared to have more mature collagen in
both the infarct zone and in the area between the patch and the cardiac surface. As the
increased collagen is consistent between the two patch groups, it is likely that the patch
increases local inflammatory response. As there was consistently more collagen in the
patch only group relative to the patch + ibuprofen group, there is a possibility that the
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ibuprofen was responsible for the difference in new
collagen deposition. Collagen I expression as shown in
Figure 20 O. supports these observations in that
collagen I expression was elevated in the groups
receiving the patch relative to the infarct only group, yet
expression in the patch + ibuprofen group was lower
than the patch only group, particularly during days 4
and 5. While this does not directly nor completely
explain the differences in the polarized light images, it
does support the overall observation that inflammation,
including

the

end-inflammatory

state

collagen

deposition, is increased with the patch use.
Tensile Mechanics
Tensile analysis following a seven-day period
showed relatively little differences between infarct only
Figure 23. Images show faint

animals and animals receiving the patch treatment.

collagen presence in infarct

However, elastic moduli were significantly increased in

area. Thicker red and orange

animals experiencing myocardial infarction compared

patches can be observed

to sham animals (Table 8; Fig. 24). While differences

around the patches. I = infarct;

in ultimate tensile strength were not determined to be

P = patch; C = collagen. Scale

statistically significant, the data suggest that cardiac

bar = 1000 μm.

tissue is weakened seven days post-MI relative to

uninjured tissue. Likewise, while statistically insignificant, a similar trend can be seen with
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fracture strength, with fracture strength decreasing in samples with infarct (Fig. 24).
Interestingly, the greatest decrease in fracture strength occurred in groups that received
the patch and supplemental ibuprofen treatment after infarct. This difference was found
to be significant between the infarct + patch + ibuprofen group and the other treatment
and sham groups. Again, while not all tensile results were statistically significant, these
data do suggest that the tissue turnover and remodeling may be exacerbated or increased
in animals receiving the patch and supplemental ibuprofen after infarct. One explanation
could be that the increased exposed collagen from the patch results in an increase in
MMPs and other proteases, leading to increased removal of damaged tissue. This is also
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supported by the slight increase in MMP-1 and MMP-2 during early inflammation as noted
in Figure 20.

Control
Infarct Only
Infarct + Patch
Infarct + Patch + IB

Elastic Modulus
(kPa)

Ultimate Tensile
Strength (kPa)

89.3 ± 73.2
102 ± 42.0 *
108 ± 88.1 *
111 ± 0.0450 *

148 ± 36.8
143 ± 33.7 *
134 ± 39.0 *
135 ± 40.3 *

Fracture Strength
(kPa)
148 ± 19.1
140 ± 18.3 *
145 ± 28.0 *
111 ± 69.7 *†

Table 7. Means and standard deviations for tensile measurements. The sham groups were
significantly different from the treatment groups (*). The ultimate tensile strength for the
infarct + patch + IB group was also significantly lower than the other groups (†). IB =
Ibuprofen.

Figure 24. Raw data graphs showing samples of data output from tensile loading.
All groups showed a similar toe region, indicating that overall composition is not
significantly different. IB = ibuprofen.
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Discussion
The function of inflammation is twofold: to clear the injured area of cell and tissue
debris, and to produce the biochemical progenitors of fibrosis and angiogenesis (Jugdutt
et al. 2007, Altara et al. 2016, Ricciotti et al. 2008). Unresolved or poorly managed
inflammation can lead to inadequate or excessive scar tissue deposition, which can have
devastating effects (Jugdutt et al. 2007, Bonaventura et al. 2016). Similarly, overactive
and underactive leukocyte activity during inflammation can lead to impaired healing and
poor left ventricular remodeling, resulting in arrhythmias and/or increased risk of heart
failure or cardiac arrest (Wan et al. 2016, Stuart et al. 2016, Giroux et al. 2000). The
border region of the infarct zone is at the greatest risk for inflammation-induced
arrhythmias, in which newly formed, non-conductive, scar tissue can affect the
surrounding, healthy tissue contractions and electrical signaling (Stuart et al. 2016). The
primary goal when using cardiac patches is to provide mechanical support; increasing
wall thickness and limiting infarct expansion. By completing these two goals, the patch
indirectly leads to a third, which is reducing the size of the border region, which leads to
lower incidences of arrhythmias (Stuart et al. 2016, Wan et al. 2013, Amer et al. 2010,
Ong et al. 2013, Olivetti et al. 1990).
Our data suggest that the use of a porcine SIS biomaterial patch does increase
the inflammation response after a 45 minute occlusion-reperfusion myocardial infarction,
either with or without supplemental ibuprofen. Importantly, the addition of the patch to the
infarct area does not appear to result in chronic inflammation, although further studies are
required to conclusively confirm this assessment. Both the PCR and cell counts analyses
showed minimal neutrophil presence and activity in the treatment groups at the end of the
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7 day period, which is an indication of resolved inflammation. Likewise, the treatments do
not appear to promote excessive or inadequate collagen production, at least within the
inflammation phase. While collagen deposition was noticeable in the patch treatment
groups, both Figures 22 and 23 show that this collagen deposition was limited to the area
immediately surrounding the patch, and therefore is unlikely to increase the risk of
pathophysiology. This is also supported by the majority of the tensile properties of all
groups. The similar elastic moduli and ultimate tensile strength of all infarct groups shows
that the patch’s presence did not significantly affect the tissue turnover in the 7 days postinfarct, relative to the infarct-only group. As excessive inflammation would have resulted
in high leukocyte infiltration and earlier deposition of collagen, the tensile testing can
provide some comparative information on the state of inflammation (Chen et al. 2013,
Shinde et al. 2014, ). By maintaining the same stiffness and relatively similar protein
composition, the patch allows inflammation to continue while providing the mechanical
support for which it is intended.
It is possible that some of the variations seen between the groups are due to this
mechanical support. Several studies have shown that application of a mechanically
supportive cardiac patch will prevent expansion of the infarct area during wound healing
(Wendel et al. 2014, Zhang et al. 2015, Robinson et al. 2005). A reduction or prevention
of injury expansion in the patch groups are supported by the downregulation of
inflammatory markers at day 7 relative to the infarct only group. It is also worth noting that
IL-RA expression is significantly increased in both treatment groups during the times that
macrophage activity is highest. This suggests that the patch presence may encourage
expression of IL-RA, resulting in slightly faster resolution of inflammation, as IL-RA
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prevents interleukin action as a receptor antagonist (RA). Faster resolution may be due
to biochemical interactions with the patch itself or, more likely, due to the patch
mechanically limiting the spread of injury and therefore, limiting the inflamed area.
Supporting this conclusion is that both TGF-β and TNF-α are expressed in lower (albeit,
statistically insignificant) levels in both treatment groups relative to infarct only expression.
This suggests that the macrophage behavior is directed towards inflammation resolution,
and not continuation as is often seen with implanted biomaterials (Wendel et al. 2014,
Zhang et al. 2015, Robinson et al. 2005, Ricciotti et al. 2011).
Interestingly, these data also suggest that low-dose NSAID treatment has minimal
effect, if any, on the wound healing process in myocardial infarction. NSAID
administration post-MI has been reviewed in a number of studies, with non-conclusive
results (Leshnower et al. 2006, Vuohelainen et al. 2016, Olivetti et al. 1990, VargasLorenzo et al. 2013). The data discussed here is supported by the body of work that
suggests that low doses of NSAIDs do not significantly alter inflammation in an injury as
severe as MI, but may assist more so in pain modification and patient comfort (Olivetti et
al. 1990, Vuohelainen et al. 2016). Importantly, these data do not suggest that ibuprofen
results in improper inflammation, either excessive or inadequate, and may be safe to use
post-MI.
Overall, this study provides adequate data to conclude that inflammation is
heightened with the porcine SIS patch treatment. However, the data does not support the
conclusion that the inflammatory process was chronic, or otherwise detrimental to moving
towards the proliferation stage of wound healing, at least compared to the infarct alone.
Therefore, we can conclude that while the patch treatment does increase inflammation,
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the treatment does not appear to affect inflammation in a manner that poses significant
risk to the long-term wound healing process. This is particularly important when compared
to the mechanical aid that the patch has been shown to provide.

106

CHAPTER 5. CONCLUSION AND FUTURE WORK
Conclusions
These studies demonstrate a broad range of how mechanical interventions can
affect soft tissue repair, both mechanically and biochemically. This work served to provide
a crucial next step in multiple fields of biomedical research, that is, the “test engineering”
phase which identifies potential complications with the design solution inside the system.
First, understanding how suturing affects skin mechanics sheds light on how a
mechanical intervention, sutures, can restore one function of skin (coverage of underlying
tissue), yet have unintended effects on the physiology. By assessing the changes in
elastic modulus, failure strength, and failure strain after suturing parallel or perpendicular
to the tensile axis, we were able to ascertain potential failure modes in sutured soft tissues
that differ from native tissue. This work demonstrates that even the most basic
mechanical interventions can have significant effects on soft tissues at the macroscopic
level.
The next study examined if mechanical interventions can affect soft tissues at a
microscopic level while simultaneously investigating a novel tissue engineering strategy
to replace damaged meniscus tissue. As adipose-derived stromal cells (ASCs) are highly
abundant and are derived from the mesenchyme, they are an ideal source for
differentiation towards a meniscus-like phenotype. By utilizing a combination of
biochemical and mechanical stimulation, we were able to alter the phenotype of the ASCs
and encourage gene expression and protein production of key meniscus proteins, such
as collagen I, collagen II, aggrecan, and versican. By exposing the ASCs to cyclic
mechanical tensile strain, we were successful in inducing fibrosis and chondrogenesis via
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the TGF-β pathway. This clearly illustrated the potential and necessity of exploring
mechanical intervention when assessing tissue engineering and regenerative medicine
treatments.
Finally, we aim to explore how a mechanical intervention can affect the
inflammation, and healing, of an active, mechanically-dependent soft tissue organ, the
heart. By utilizing concepts on the impact of suturing on dynamic soft tissues as well as
the effects of mechanical forces on the cellular level, we designed an experiment to
assess how the addition of a collagen-based cardiac patch can affect the inflammation,
and ultimately the long-term prognosis, of a rat myocardial infarction model. By comparing
the inflammatory response using gene expression, histology, and inflammatory cell
population and density, we can reasonably gauge how this cardiac patch model will affect
inflammation, and therefore wound healing in a rat infarct model.
The implications of this body of work suggest that mechanical interventions will
play a critical and prominent role in many tissue engineering and regenerative medicine
applications. In particular, the future body of work concerning the use of cardiac patches
to attenuate tissue necrosis and scar tissue bulging in myocardial infarction is of particular
importance. After assessing the initial inflammation status in a patch model, it would be
prudent to evaluate the long term impact of the patch. This analysis would consider not
only mechanical benefits from the patch reinforcement, but how the presence of the patch
affects the proliferation and maturation in the infarct. Furthermore, should the results of
future work suggest that the patch model significantly aids in the promotion of wound
healing in a myocardial infarct model, it would be prudent to optimize the size and material
of the patch. Both of these parameters stand to affect the mechanics of the surrounding
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tissue, including wall thickness, stiffness, and stress shielding. Altering these parameters
may further improve patient outcomes.
Future Directions
Beyond the tasks of developing an ECM structure and developing an antiimmunogeneic cell source, there is still much work to be done before a reasonable tissue
developed in vitro can be implemented in vivo. One of the most critical components of
most tissues is vasculature, yet very few studies address vasculature when publishing
work about a novel tissue. In fact, a number of highly publicized studies use decellularized
tissues and stem cells to create “whole” organs to much fanfare (Guyette 2016). However,
these organ structures do not contain a vascular network and would therefore fail quickly
if removed from the cell culture media. This is not to criticize these great works, but to
highlight how the typical approach of ECM + cells is lacking some of the most crucial
elements of a functional tissue.
The lack of vasculature is one of the many reasons why connective tissues and
avascular tissues, such as meniscus, are so attractive to tissue engineers. Connective
tissues tend to be lower cell density, placing a higher priority on excellent ECM structure.
This excellent ECM structure can be obtained through decellularization processes, while
the lower cell population can be provided by stem cells.

109

REFERENCES
1. Altara R, Manca M, Sabra R, Eid A, Booz GW, Zouein FA. (2016) Temporal cardiac
remodeling post-myocarial infarction: dynamics and prognostic implications in
personalized medicine. Heart Fail Rev 21(25): 25-47.
2. Amer M, Bead VR, Bathon J, Blumenthal RS, & Edwards DN. (2010) Use of Nonsteroidal
Anti-Inflammatory Drugs in Patients With Cardiovascular Disease. Cardiology in Review
18:204-212.
3. Arendt EA, Miller LE, & Block JE (2014) Early Knee Osteoarthritis Management Should
First Address Mechanical Joint Overload. Orthop Rev (Pavia) 6: 5188.
4. Baker BM, Nathan AS, Huffman Russell G, & Mauck RL. (2009) Tissue engineering with
meniscus cells derivced from surgical debris. Osteoarthritis and Cartilage 17: 336-345.
5. Baptista LS, Silva KR, Pedrosa CSG, Amaral RJ, Belizario JV, Borojevic R, & Granjeiro
JM. (2013) Bioengineered cartilage in a scaffold-free method by human cartilage-derived
progenitor cells: a comparison with human adipose-derived mesenchymal stromal cells.
Artificial Organs 37(12): 1068-1075.
6. Beck EC, Barragan M, Tadros MH, Gehrke SH, Detamore MS. (2016) Approaching the
compressive modulus of articular cartilage with a decellularized cartilage-based hydrogel.
Acta Biomaterialia. 38: 94-105
7. Boag S, Andreano E, Spyridopoulos I. (2016) Lymphocyte Communication in Myocardial
Ischemia/Reperfusion Injury. Article In Press
8. Bonaventura A, Montecucco F, & Dallegri F. (2016) Cellular recruitment in myocardial
ischaemia/ reperfusion injury. Eur J Clin Invest 46 (6): 590-601.

110

9. Boza P, Ayala P, Vivar R, Humeres C, Cacere FT, Munoz C, Garcia L, Hermoso MA, &
Diaz-Araya G. (2016). Expression and function of toll-like receptor 4 and inflammasomes
in cardiac fibroblasts and myofibroblastsL IL-1β synthesis, secretion, and degradation.
Mol Immunol. 74: 96-105.
10. Bouyarmane H, Beaufils P, Pujol N, Bellemans J, Roberts S, & Spalding T. (2014)
Polyurethane scaffold in lateral meniscus segmental defects: clinical outcomes at 24
months follow-up. Orthop Traumatol Surg Res 100:153-157.
11. Brophy RH, & Matava MJ. (2012) Surgical options for meniscal replacement. J Am Acad
Orthop Surg 20: 265.
12. Buma P, Ramrattan NN, van Tienen TG, & Veth RPH. (2004) Tissue engineering of the
meniscus. Biomaterials 25(1): 1523-1532.
13. Byrne EM, Farrell E, McMahon LA, Haugh MG, O'Brien FJ, Campbell VA. (2008) Gene
expression by marrow stromal cells in a porous collagen-glycosaminoglycan scaffold is
affected by pore size and mechanical stimulation. J Mater Sci Mater Med 19:3455-3463.
14. Caimi G, Lo Presti R, Canino B, Ferrera E, & Hopps E. (2015) Behaviour of the neutrophil
to lymphocyte ratio in young subjects with acute myocardial infarction. Clinical
Hemorheology and Microcirculation. Article In Press.
15. Capek L, Jacquet E, Dzan L, Simunek A. (2012) The analysis of forces needed for the
suturing of elliptical skin wounds. Med Biol Eng Comput. 50(2):193-8.
16. Carrino DA, Calabro A, Darr AB, Dours-Zimmermann MT, Sandy JD, Zimmermann DR,
Sorrell JM, Hascall VC, & Caplan AI. Age-related differences in human skin
proteoglycans. Glycobiology 2: 257-268.

111

17. Case N, Thomas J, Xie Z, Sen B, Styner M, & Rowe D. (2013) Mechanical input restrains
PPARγ2 expression and action to preserve mesenchymal stem cell multipotentiality.
Bone 52: 454-464.
18. Chanda A, Unnikrishnan V, Flynn Z, Lackey K. (2016) Experimental study on tissue
phantoms to understand the effect of injury and suturing on human skin mechanical
properties. Proceedings of the Institution of Mechanical Engineers part H. 231.
19. Chen W, & Frangogiannis NG. (2013) Fibroblasts in post-infarction inflammation and
cardiac repair. Biochimica et Biophysica Acta 1833: 945-953.
20. Cheung HS, Huang CY, & Pelaez D. (2009) Cyclic compression maintains viability and
induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds. Stem
Cells and Development 18(1): 93-100.
21. Chia HN, & Hull ML. (2008) Compressive Moduli of the Human Meniscus in the Axial and
Radial Direction at Equilibrium and at Physiological Strain Rate. Journal of Orthopedic
Research 8: 951-956.
22. Chu B, & Deshmukh, N. (1989) The lack of effect of pentoxifylline on random skin flap
survival. Plastic and Reconstructive Surgery 83: 315-318.
23. Connelly JT, Vanderploeg EJ, Mouw JK, Wilson CG, & Levenston ME. (2010) Tensile
Loading Modulates Bone Marrow Stromal Cell Differentiation and the Development of
Engineered Fibrocartilage Constructs. Tissue Eng A 16: 1913-1923.
24. Corr, DT, & Hart DA. (2011) Biomechanics of Scar Tissue and Uninjured Skin. Advances
in Wound Care (2)2: 37-43.

112

25. D’Amore A, Yoshizumi T, Luketich SK, Wolf MT, Gu X, Cammarata M, Hoff R, Badylak
SF, Wagner WR. (2016) Bi-layered polyurethane- Extracellular matrix cardiac patch
improves ischemic ventricular wall remodeling in a rat model. Biomaterials 107: 1-14.
26. Edwards D, & Elson R. (1995) Skin closure using nylon and polydioxanone: a comparison
of results. Journal of the Royal College of Surgeons of Edinburgh 40: 342-353.
27. Feng L, Moore XL, Dart AM, Wang LM. (2015) Systemic inflammatory response following
acute myocardial infarction. J Geriatr Cardiol. 12:305-312.
28. Frangogiannis NG, Smith CW, Entman ML. (2002) The inflammatory response in
myocardial infarction. Cardiovascular Research 53: 31-47
29. Galie PA, Khalid N, Carnahan KE, Westfall MV, & Stegemann JP. (2013) Substrate
stiffness affects sarcomere and costamere structure and electrophysiological function of
isolated adult cardiomyocytes. Cardiovascular Physiology 22(1): 219-227.
30. Geissman F, Gordon S, Hume DA, Mowat AM, & Randolph GJ. (2010) Unraveling
mononuclear phagocyte heterogeneity. Nature Reviews Immunology 10(6): 453-460.
31. Gerdisch MW, Shea RJ, Barron MD.(2014). Clinical experience with CorMatrix
extracellular matrix in the surgical treatment of mitral valve disease. J Thorac Cardiovasc
Surg. 148:1370-8.
32. Grady E, Elder S, Ryan P, Swiderski C, & Rashmir-Raven A. (2009) Biomechanical and
molecular characteristics of hereditary equine regional dermal asthenia in Quarter
Horses. Veterinary Dermatology 20: 591-599.
33. Greenwald D, Shumway S, Albear P, & Gottlieb L. (1994) Mechanical Comparison of 10
Suture Materials before and after in Vivo Incubation. Journal of Surgical Research 56:
372-377.

113

34. Giroux M, & Descoteaux A. (2000). Cyclooxygenase-2 Expression in Macrophages.
Modulation by Protein Kinase C-α. J Immunol 165: 3985-3991.
35. Godwin JW, Pinto AR, & Rosenthal NA. (2016) Chasing the recipe for a pro-regenerative
immune system. Sem Cell Dev Biol. Article in Press.
36. Harries RL, Bosanquet DC, Harding KG. (2016) Wound bed preparation: TIME for an
update. International Wound Journal. Article In Press.
37. Hasan J, Fisher J, & Ingham, E. (2014) Current strategies in meniscal regeneration. J
Biomed Mater Res B Appl Biomater 102: 619.
38. Hatsushika D, Muneta T, Nakamura T, Horie M, Koga H, & Nakagawa, Y. (2014)
Repetitive allogeneic intraarticular injections of synovial mesenchymal stem cells promote
meniscus regeneration in a porcine massive meniscus defect model. Osteoarthritis
Cartilage 22: 941-950.
39. Higashioka MM, Chen JA, Hu JC, & Athanasiou KA. (2014) Building an anisotropic
meniscus with zonal variations. Tissue Eng Part A 20: 294.
40. Holzapfel, GA. (2000) Biomechanics of Soft Tissue. Computational Biomechanics 7(1):
1-15.
41. Ibrahim A, Ayeni OA, Hughes KB, Lee BT, Slavin SA, Lin SJ. (2013). Acellular Dermal
Matrices in Breast Surgery. Annals of Plastic Surgery 70(6):732-740.
42. Iyer RP, Jung M, Lindsey ML. (2016) MMP-9 signaling in the left ventricle following
myocardial infarction. Am J Physiol Heart Circ Physiol 311: H190-H198.
43. Jansen LA, De Caigny P, Guay N, Lineaweaver WC, Shokrollahi K. (2013) The Evidence
Base for the Acellular Dermal Matrix AlloDerm. Ann Plast Surg 70: 587-594.

114

44. Jugdutt BI, Halliday I, & Uwiera RE. (2007) Therapeutic drugs during healing after
myocardial infarction modify infarct collagens and ventricular distensibility at elevated
pressures. Mol Cell Biochem 304: 79-91.
45. Kapellos TS, Iqbal AJ. (2016) Epigenetic control of macrophage polarisation and soluble
mediator gene expression during inflammation. Mediators of Inflammation. 6(59): 1-15.
46. Kessler D, Dethlefsen S, Haase I, Plomann M, Hirche F, & Krieg, T. (2001) Fibroblasts
in mechanically stressed collagen lattices assume a "synthetic" phenotype. J Biol Chem
276: 36575-36585.
47. Khani MM, Tafazzoli-Shadpour M, Goli-Malekabadi Z, Haghighipour N. Mechanical
characterization of human mesenchymal stem cells subjected to cyclic uniaxial strain and
TGF-B1. J Mech Behav Biomed Mater 43:18-25. 2015.
48. Kirkby NS, Tesfai A, Ahmetaj-Shala B, Gashaw HH, Sampaio W, Etelvino G, Leao NM,
Santos RA, Mitchell JA. Ibuprofen arginate retains eNOS substrate activity and reverses
endothelial dysfunction: implications for the COX2/ADMA axis. The FASEB Journal. 30:17.
49. Kisiday JD, Frisbie DD, McIlwraith CW, & Grodzinsky AJ. (2009) Dynamic compression
stimulates proteoglycan synthesis by mesenchymal stem cells in the absence of
chondrogenic cytokines. Tissue Eng Part A 15: 2817-2824.
50. Kokai LE, Marra KJ, & Rubin JP. (2014) Adipose stem cells: biology and clinical
applications for tissue repair and regeneration. Translational Research 163(4): 399-408.
51. Kong J, Grando SA, & Li YC. (2006) Regulation of IL-1 Family Cytokines IL-1α, IL-1
Receptor Antagonist, and IL-18 by 1,25 Dihydroxyvitamin D3 in Primary Keratinocytes.
The Journal of Immunology 176: 3780-3787

115

52. Kun M, Titan AL, Stafford M, Zheng CH, & Levenston ME. (2012) Variations in
chondrogenesis of human bone marrow-derived mesenchymal stem cells in
fibrin/alginate blended hydrogels. Acta Biomaterialia 8(10): 3754-3764.
53. Lam MT, Huang YC, Birla RK, & Takayama S. (2009) Microfeature guided skeletal
muscle tissue engineering for highly organized 3-dimensional free-standing constructs.
Biomaterials 30(6):1150-1155.
54. Lam MT, Nauta A, Meyer NP, Wu JC, & Longaker MT. (2013) Effective Delivery of Stem
Cells Using an Extracellular Matrix Patch Results in Increased Cell Survival and
Proliferation and Reduced Scarring in Skin Wound Healing. Tissue Engineering A 19:
738-747.
55. Lam MT, Wu JC (2012). Biomaterial applications in cardiovascular tissue repair and
regeneration. Expert Rev Cardiovasc Ther. 10(8): 1039-49.
56. Langton AK, Graham HK, McConnell JC, Sherratt MJ, Griffiths CEM, Watson REB.
(2017) Organisation of the dermal matrix impacts the biomechanical properties of skin.
British Journal of dermatology. Article in Press.
57. Leshnower BG, Sakamoto H, Zeeshan A, Parish LM, & Gorman RC. (2006) Role of
acetaminophen in acute myocardial infarction. Heart and Circulatory Physiology 290:
H2424-2431.
58. Levi K, Ichiryu K, Kefel P, Keller J, Grice J, Belson O, Storne E, Safa B. (2016) Mechanics
of wound closure: emerging tape-based would closure technology vs. traditional methods.
Cureus. 8(10):86.

116

59. Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart M. Mechanical load modulates chondrogenesis
of human mesenchymal stem cells through the TGF-B pathway. J Cell Mol Med. 14:13381346. 2010.
60. Lister Z, Rayner KJ, Suuronen EJ. (2016) How Biomaterials Can Influence Various Cell
Types in the Repair and Regeneration of the Heart after Myocardial Infarction. Front
Bioeng Biotechnol (4):62.
61. Longo UG, Rizzello G, Berton A, Fumo C, Battaglia G, & Khan WS. (2013) A review of
preclinical and clinical studies using synthetic materials for meniscus replacement. Curr
Stem Cell Res Ther 8: 438-443.
62. Makris EA, Hadidi P, & Athanasious A. (2004) The knee meniscus: Structure-function,
pathophysiology, current repair techniques, and prospects for regeneration. Biomaterials
32: 7411-7431.
63. Mandal BB, Park SH, Gil ES, & Kaplan DL. (2011) Stem cell-based meniscus tissue
engineering. Tissue Eng Part A. 17: 2749-2761.
64. McDermott ID, Masouros SD, & Amis AA. (2008) Biomechanics of the meniscus of the
knee. Current Orthopaedics 22: 193-201.
65. Meier EM, Lam MT. (2016) Role of Mechanical Stimulation in Stem Cell Differentiation.
JSM Biotechnology and Biomedical Engineering. Article in Press.
66. Meier EM, Wu B, Siddiqui A, Tepper D, Lam MT. (2016) Mechanical Stimulation
Increases RNA-level expression of Knee Meniscus Genes in Adipose-Derived Stromal
Cells. Plastic and Reconstructive Surgery. 16;4(9):e864.

117

67. Mewhort HEM, Turnball JD, Meijndert HC, Ngu JMC, Fedak PWM. (2014) Epicardial
infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial
attenuates postischemic cardiac remodeling. J Thorac Cardiovasc Surg 147:1650-9.
68. Mikic B, Johnson TL, Chhabra AB, Schalet BJ, Womng M, & Hunziker EB. (2000)
Differential effects of embryonic immobilization on the development of fibrocartilaginous
skeletal elements. Journal of Rehabilitation Research and Development 37(2): 127-133.
69. Miller, K. (2000) Biomechanics of soft tissues. Medical Science Monitor 6: 158-167.
70. Naal FD, Schauwecker J, Steinhauser E, Milz S, von Knoch F, & Mittelmeier W. (2008)
Biomechanical and immunohistochemical properties of meniscal cartilage after high
hydrostatic pressure treatment. J Biomed Mater Res B Appl Biomater 87: 19-25.
71. Nah DY, Rhee MY. (2009) The Inflammatory Response and Cardiac Repair After
Myocardial Infarction. The Korean Society of Cardiology. 39:393-398.
72. Nerurkar NL, Han W, Mauck RL, & Elliott DM. (2011) Homologous structure-function
relationships between native fibrocartilage and tissue engineered from MSC-seeded
nanofibrous scaffolds. Biomaterials 32: 461-468.
73. Nishimuta JF, & Levenston ME. (2012) Response of cartilage and meniscus tissue
explants to in vitro compressive overload. Osteoarthritis and Cartilage 5(20): 422-429.
74. Oh SJ, Kim Y. (2011) Combined AlloDerm and thin skin grafting for the treatment of
postburn dyspigmented scar contracture of the upper extremity. Journal of Plastic
Reconstructive and Aesthetic Surgery 64, 229-233.
75. Okuno M, Muneta T, Koga H, Ozeki N, Nakagawa Y, & Tsuji K. (2014) Meniscus
regeneration by syngeneic, minor mismatched, and major mismatched transplantation of
synovial mesenchymal stem cells in a rat model. J Orthop Res 32: 928-936.

118

76. Olsen AM, Fosbol EL, Lindhardsen J, Folke F, Charlot M, Selmer C, Lambers M, Olsesen
JB, Kober L, Hansen PR, Torp-Pedersen C, Gislason G. (2011). Duration of Treatment
With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent
Myocardial Infarction in Patients with Prior Myocardial Infarction. Circulation. 123: 22262235.
77. Olivetti G, Capasso JM, Sonnenblick EH, & Anversa P. (1990) Side-to-Side Slippage of
Myocytes Participates in Ventricular Wall Remodeling Acutely After Myocardial Infarction
in Rats. Circulation Research 6: 23-34.
78. Ong HT, Ong LM, Tan TE, & Chean KY. (2013) Cardiovascular Effects of Common
Analgesics. Med J Malaysia 68: 189- 176.
79. Otsubo H. (2016) Repair of Acute Patellar Tendon Rupture Augmented with Strong
Sutures. J Knee Surg. 1538-8506.
80. Pak J, Lee JH, & Lee SH. (2014) Regenerative repair of damaged meniscus with
autologous adipose tissue-derived stem cells. Biomed Res Int. 3: 436029-436039.
81. Pak J, Lee JH, & Lee SH. (2014) Regenerative repair of damaged meniscus with
autologous adipose tissue-derived stem cells. BioMed Research International.
82. Park JH, Ushida T, & Akimoto T. (2013) Control of cell differentiation by mechanical
stress. J Phys Fitness Sports Med 2(1): 49-62.
83. Patel P, Parikh M, Shah H, Gandhi T. (2016) Inhibition of RhoA/Rho kinase by ibuprofen
exerts cardioprotective effect on isoproterenol induced myocardial infarction in rats.
European Journal of Pharmacology. 791: 91-98.
84. Patrono C. Cardiovascular Effects of Nonsteroidal Anti-Inflammatory Drugs. Curr Cardiol
Rep. 18:25-32.

119

85. Pelaez D, Huang CC, & Cheung HS. (2009) Cyclic compression maintains viability and
induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds. Stem
Cells and Development 1: 93-102.
86. Perea-Gil I, Prat-Vidal C, & Bayes-Genis A. (2015) In vivo experience with natural
scaffolds for myocardial infarction: the times they are a-changin’. Stem Cell Res Ther 6:
248-256
87. Petri M, Ufer K, Toma I, & Becher C. (2012) Effects of perfusion and cyclic compression
on in vitro tissue engineered meniscus implants. Knee Surg Sports Traumatal Arthrosc
20: 223-231.
88. Przyklenk K. (2013). Reduction of Myocardial Infarct Size with Ischemic “Conditioning”:
Physiologic and Technical Considerations. Anesth Analg. 117:891-901.
89. Przyklenk K. (2015). Ischemic conditioning: pitfalls on the path to clinical translation.
British Journal of Pharmacology. 172: 1961-1973.
90. Przyklenk K, Dong Y, Undyala VV, Whittaker P. (2012) Autophagy as a therapeutic target
for

ischaemia/reperfusion

injury?

Concepts,

controversies,

and

challenges.

Cardiovascular Research. 94: 197-205.
91. Qazi SM, Sindby EJ, Norgaard MA. (2015) Ibuprofen-a Safe Analgesic During Cardiac
Surgery Recovery? A Randomized Controlled Trial. J Cardiovasc Thorac Res. 7(4): 141148.
92. Ricciotti E, & FitzGerald GA. (2011) Prostaglandins and Inflammation. Arterioscler
Thromb Vasc Biol 31(5): 986-1000.

120

93. Rich L and Whittaker P. (2005) Collagen and Picrosirius Red staining: a polarized light
assessment of fibrillary hue and spatial distribution. Journal of Morphological Sciences
22: 97-104.
94. Robinson KA, Li J, Mathison M, Redkar A, Cui J, Chronos NAF, Matheny RG, & Badylak
SF. (2005) Extracellular Matrix Scaffold for Cardiac Repair. Circulation 112: I-135-I-143.
95. Roeder C, & Driesch P. (1999) Psoriatic erythroderma and bullous pemphigoid treated
successfully with acitretin and azathioprine. European Journal of Dermatology 9: 537539.
96. Rongen JJ, van Tienen TG, van Bochove B, Grijpma DW, & Buma P.(2014) Biomaterials
in search of a meniscus substitute. Biomaterials 35: 3527.
97. Rothrauff BB, Numpaisal PO, Lauro BB, Alexander PG, Debski RE, Musahl V, Tuan RS.
(2016) Augmented repair of radial meniscus tear with biomimetic electrospun scaffold: an
in vitro mechanical analysis. J Exp Orthop 3(1):23-30.
98. Roussis PC, Giannakopoulos AE, Charalambous HP. (2015) Suture line response of
end-to-side anastomosis: A stress concentration methodolody. Cardiovasc Eng Techno
6(1):36-48.
99. Saha S, Ji L, de Pablo JJ, Palecek SP. Inhibition of human embryonic stem cell
differentiation by mechanical strain. J Cell Physiol. 206:126-137. 2006.
100. Saha S, Ji L, de Pablo JJ, Palecek SP. TGFB/Activin/Nodal Pathway in Inhibition of
Human Embryonic Stem Cell Differentiation by Mechanical Strain. Biophys J. 94:41234133. 2008.

121

101. Saulis A, Lautenschlager E, & Mustoe T. (2002) Biomechanical and viscoelastic
properties of skin, SMAS, and composite flaps as they pertain to rhytidectomy 110: 177183.
102. Schleip R, & Muller DG. (2013) Training principles for fascial connective tissues:
Scientific foundation and suggested practical applications. Journal of Bodywork and
Movement Therapies 17(1): 103-155.
103. Schüttler KF, Pöttgen S, Getgood A, Rominger MB, Fuchs-Winkelmann S, & Roessler
PP. (2014) Improvement in outcomes after implantation of a novel polyurethane meniscal
scaffold for the treatment of medial meniscus deficiency. Knee Surg Sports Traumatol
Arthrosc 7: 1929-1935.
104. Scotti C, Hirschmann MT, Antinolfi P, Martin I, & Peretti GM. (2013) Meniscus repair
and regeneration: review on current methods and research potential. Eur Cell Mater 26:
150.
105. Selvi E, Manganelli S, Catenaccio M, De Stefano R, Frati E, Cucini S, & Marcolongo R.
(2000) Diff Quik staining method for detection and identification of monosodium urate and
calcium phosphate crystals in synovial fluids. Ann Rheum Dis 60:194-198.
106. Sen B, Guilluy C, Xie Z, Case N, Styner M, Thomas J, Oguz I, Rubin C, Burridge K,
Rubin J. Mechanically Induced Focal Adhesion Assembly Amplifies Anti-Adipogenic
Pathways in Mesenchymal Stem Cells. Stem Cells. 29:1829-1836. 2011.
107. Serpooshan V, Zho M, Metzler SA, Wei K, Shah PB, Wang A, Mahmoudi M, Malkovskiy
AV, Rajadas J, Butte MJ, Bernstein D, Ruiz-Lozano P. (2013). The effect of
bioengineered acellular collagen patch on cardiac remodeling and ventricular function
post myocardial infarction. Biomaterials 34:9048-9055.

122

108. Shahabiour F, Banach M, Johnston TP, Pirro M, Sahebkar. (2016) Novel approaches
toward the generation of bioscaffolds as a potential therapy in cardiovascular tissue
engineering. International journal of cardiology. 228 319-326.
109. Shinde AV, & Frangogiannis NG. (2014) Fibroblasts in myocardial infarction: A role in
inflammation and repair. Journal of Molecular and Cellular Cardiology 70:74-82.
110. Shwartz Y, Blitz E, & Zelzer E. (2013) One load to rule the all: Mechanical control of the
musculoskeletal system in development and aging. Differentiation. 86(3): 104-111.
111. Silverman, JF. Inflammatory and neoplastic processes of the lung: differential diagnosis
and pitfalls in FNA biopsies. Diagnostic Cytopathy 13(5): 448-462.
112. Son M, Goodman SB, Chen W, Hargreaves BA, Gold GE, & Levenston ME. (2013)
Regional variation in T1p and T2 times in osteoarthritic human menisci: correlation with
mechanical properties and matrix composition. Osteoarthritis and Cartilage 6(21): 796805.
113. Stuart SD, De Jesus NM, Lindsey ML. (2016) Ripplinger, CM. The crossroads of
inflammation, fibrosis, and arrhythmia following myocardial infarction. Journal of
Molecular and Cellular Cardiology 91: 114-122.
114. Stuart SDF, De Jesus NM, Lindsey ML, & Ripplinger CM. (2016) The crossroads of
inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Car 91:
114-122.
115. Sutherland AJ, Converse GL, Hopkins RA, Detamore MS. 2015. The bioactivity of
cartilage extracellular matrix in articular cartilage regeneration. Adv Healthc Mater. 4(1):
29-39.

123

116. Tan MY, Zhi W, Wei RQ, Huang YC, Zhou KP, Tan B, Deng L, Luo JC, Li XQ, Xie HQ,
Yang ZM. (2009). Repair of infarcted myocardium using mesenchymal stem cell seeded
small intestinal submucosa in rabbits. Biomaterials. 30:3234-3240.
117. Teramura T, Takehara T, Onodera Y, Nakagawa K, Hamanishi C, Fukuda K.
Mechanical stimulation of cyclic tensile strain induces reduction of pluripotent related
gene expressions via activation of Rho/ROCK and subsequent decreasing of AKT
phosphorylation in human induced pluripotent stem cells. Biochem Biophys Res Commun
417:836-841. 2012
118. Thambyah A, Nather A, & Goh J. (2006) Mechanical properties of articular cartilage
covered by the meniscus. Osteoarthritis and Cartilage 14: 580-588.
119. Toeg HD, Tiwari-Pandey R, Seymour R, Ahmadi A, Crowe S, Vulesevic B, Suuronen
EJ, Ruel M. (2013). Injectable Small Intestine Submucosal Extracellular Matrix in an
Acute Myocardial Infarction Model. Ann Thorac Surg 96:1686-94.
120. Turer AT, & Hill JA. (2010) Pathogenesis of Myocardial Ischemia-Reperfusion Injurt and
Rationale for Therapy. Am J Cardiol 106(3): 360- 368
121. Van den Berg TK, Puklavec MJ, Barclay AN, Dijkstra CD. (2001) Monoclonal antibodies
against rat leukocyte surface antigens. Immunological Reviews. 183:109-116.
122. Van Hout GPJ, van Solinge WW, Gijsberts CM, & Hoefer IE. (2015). Elevated mean
neutrophil volume represents altered neutrophil composition and reflects damage after
myocardial infarction. Basic Res Cardiol 110: 58-69
123. Vangsness CT Jr., Farr J 2nd, Boyd J, Dellaero DT, Mills CR, & LeRoux-Williams M.
(2014) Adult human mesenchymal stem cells delivered via intra-articular injection to the

124

knee following partial medial meniscectomy: a randomized, double-blind, controlled
study. J Bone Joint Surg Am 96: 90-98.
124. Vargas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F,
Sturkenboom M, & Perez-Gutthann S. (2013) Myocardial infarction and individual
nonsteroid

anti-inflammatory

drugs

meta-analysis

of

observational

studies.

Pharamcoepidemiol Drug Saf 22(6): 559-570.
125. Vesentini S, Redalli A, & Montevecchi F. (2003) Skin Nanostructural Features
Determine Suture Biomechanics. Transactions on Nanobioscience 2: 79-87.
126. Voorhees AP, DeLeon-Pennell KY, Ma Y, Halade GV, Yabluchanskiy A, Iyer RP, Flynn
E, Cates CA, Lindsey ML, Han HC. (2015). Building a better infarct: Modulation of
collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation postmyocardial infarction. Journal of Molecular and Cellular Cardiology. 85:229-239.
127. Vuohelainen V, Paavonen T, Hamalainen M, Moilanen E, & Mennander AA. (2014) C4d
Deposition Reveals Myocardial Infarction After Cardiac Arrest- Experimental Study. Adv
Clin Exp Med Article in Press.
128. Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, & Thorp EB. (2013) Enhanced
Efferocytosis of Apoptotic Cardiomyocytes Through Myelod-Epithelial-Reproductive
Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction.
Circulation Research 113: 1004-1012.
129. Wan F, Letavernier E, Jourdan Le Saux C, Houssani A, Abid S, Czibik G, Sawaki D,
Marcos E, Dubois-Rande JL, Baud, L, Adnot S, Derumeaux G, & Gellen B. (2015)
Calpastatin Overexpression Impairs Post-infarct Scar Healing in Mice by Compromising

125

Reparative Immune Cell Recruitment and Attachment. Am J Physiol Heart Circ Physiol.
Article In Press.
130. Wan L, Chan Y, Wang Z, Wang W, Schmull S, Dong J, Xue S, Imboden H, Li J. (2017)
Human heart valve- derived scaffold improves cardiac repair in a murine model of
myocardial infarction. Sci Rep. Article in Press.
131. Wan Z, Zheng S, Fan Y, Liu K, Du F, Davey AM, Zhang H, Han W, Xiong C, & Liu W.
(2013) B Cell Activation Is Regulated by the Stiffness Properties of the Substrate
Presenting the Antigens. The Journal of Immunology 190: 4661-4675.
132. Wang A, Kleinerman R, Armstrong A, Fitzmaurice S, Pascucci A, Awasthi S,
Ratnarathorn M, Sivamani R, King T, & Eisen D. (2014) Set-back buried vertical mattress
suturing: results of a randomized blinded trial. Journal of American Academy of
Dermatology 72: 674-680.
133. Wendel JS, Ye L, Zhang P, Tranquillo RT, & Zhang JJ. (2014) Functional
Consequences of a Tissue-Engineered Myocardial Patch for Cardiac Repair in a Rat
Infarct Model. Tissue Engineering A 20: 1325-1335.
134. Wenger MPE, Bozec, L, Horton MA, & Mesquida P. (2007) Mechanical Properties of
Collagen Fibrils. Biophysical Journal 93: 1255-1263.
135. Whittaker P, & Przyklenk K. (2009) Fibrin architecture in clots: A quantitative polarized
light microscopy analysis. Blood Cells Mol Dis 42: 51-56.
136. Xu Y, Malladi P, Chiou M, Bekerman E, Giaccia AJ, Longaker MT. (2007) In vitro
expansion of adipose-derived adult stromal cells in hypoxia enhances early
chondrogenesis. Tissue Eng 13: 2981-2993.

126

137. Yuan X, Arkonac DE, Chao PH, & Vunjak-Novakovic G. (2014) Electrical stimulation
enhances cell migration and integrative repair in the meniscus. Sci Rep 4: 3674.
138. Zhang J (2015) Engineered Tissue Patch for Cardiac Cell Therapy. Curr Treat Options
Cardio Med 17: 37-48.
139. Zhu F, Dong L, Jin X, Jiang B, Kalra A, Shen M, & Yang K. (2015) Testing and modeling
the responses of Hybrid III Crash-Dummy Lower Extremity under high-speed vertical
loading. Stapp Car Crash Journal 59: 521-536.

127

ABSTRACT
MECHANICAL INTERVENTIONS IN SOFT TISSUE REPAIR
by
ELIZABETH MEIER
May 2017

Advisor: Dr. Mai Lam
Major: Biomedical Engineering
Degree: Doctor of Philosophy

This body of work sets to investigate some of these mechanical interventions that
are designed to promote wound healing, repair, or even replace an injured tissue. By
investigating three separate tissues and three separate mechanical interventions, we can
draw conclusions about the implications of including mechanical interventions in
biomedical research and clinical treatments. The use of sutures to close wounds is highly
common, however the effects of sutures on the tensile mechanics of human skin are
largely unknown. To evaluate how sutures may affect uniaxial tensile mechanics, human
skin samples were sutured and loaded in tension in multiple orientations. The data
suggested that the sutured skin had a lower fracture strength and higher elastic modulus
than the intact skin, particularly when loaded in-line with the injury. Next, the inflammatory
effects of a decellularized ECM patch in a myocardial infarction model were analyzed. A
commercially available decellularized material, porcine small intestine submucosa, was
evaluated as a patch treatment in a rat myocardial infarction model, a treatment that is
common in cardiac research. As anticipated, the addition of the patch in the injury area
increased local inflammation as indicated by gene expression and leukocyte population
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and density. However, the patch did not appear to extend the inflammation response nor
affect the response in a manner that would suggest hindrance to wound healing. Thirdly,
a unique biochemical and mechanical approach was used to direct human adipose stem
cells to differentiate towards a meniscus-like phenotype. By using a variety of media
formulations and a variation of uniaxial tensile parameters, a protocol to maximize
meniscus gene expression was concluded. A chondrogenic media formulation with 10%
uniaxial strain at 1 Hz for 3 hours was found to have the greatest increase in meniscus
gene expression of all of the parameters tested. Together, each of these individual works
contributes to the conclusion that mechanical interventions can have a significant impact
on the restructuring, repair, and replacement of soft tissues.
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